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INTRODUCTION:  CALCIUM SIGNALING IN ENTERIC GLIA 
[Note:  This chapter has been slightly modified from a manuscript published in the 2001 
edition of Recent Research Developments in Neurochemistry, Research Signpost, Inc.] 
 
Abstract 
The enteric nervous system serves to regulate the gastrointestinal tract.  Within 
this intricate network, enteric neurons have been previously well characterized whereas 
enteric glia have not.  In recent years, our understanding of enteric glia has increased 
substantially.  Rather than simply playing a passive role in the gut, it now appears that 
glia act as active, integral components in the enteric nervous system.  Like glia of the 
central nervous system, enteric glia respond to a variety of neuroligands with calcium 
signaling.  Two such agonists are adenosine triphosphate (ATP) and endothelin (ET).  In 
addition to mobilizing intracellular calcium stores through receptor-mediated signal 




review summarizes the current knowledge of signaling events in enteric glia while giving 






The enteric nervous system (ENS) is the largest division of the peripheral nervous 
system (PNS) and is derived embryologically from the neural crest like all other PNS 
components (1).  The ENS, considered a separate class of the autonomic nervous system 
distinct from sympathetic and parasympathetic branches (2), participates in virtually all 
aspects of gastrointestinal (GI) function, including blood flow, secretion, absorption, and 
motility (for reviews see: 3-12).  A cross-sectional diagram of the GI tract [Figure 1.1] 
shows that the ENS is composed of two intrinsic networks, the submucosal plexus 
(Meissner’s plexus) and the myenteric plexus (Auerbach’s plexus) [Figure 1.2], each 
containing interconnected enteric ganglia.  The innermost submucosal plexus is situated 
beneath the intestinal mucosal layer where it regulates epithelial absorption and secretion.  
The myenteric plexus, embedded between the circular and longitudinal smooth muscle 
layers, modulates intestinal motility. 
Two major cell types comprise the ENS: neurons and glia [Figure 1.3].  Within 
the ENS, neurons have historically received considerably more investigative attention 
than glia.  Enteric neurons are as numerous as their counterparts in the spinal cord and 
neural networks have been extensively mapped throughout the GI tract.  Classical 
electrophysiological evaluation of canine intestinal function led to the discovery that the 
ENS has the ability to locally mediate reflexes, such as the control of peristalsis, without 
input from the CNS (13).  Given its autonomous function, the ENS is also known as, 




established, understanding of enteric glia, while evolving, is much less developed.  This 
review serves to discuss current knowledge of signaling events in these cells. 
 
Enteric Glia -- Active Participants in ENS Signaling 
 
Over two decades ago it became apparent that the enteric nervous system 
contained a non-neuronal cell type which was quite different from Schwann cells of the 
PNS and yet similar to astrocytes of the CNS.  From a population standpoint, glial cells 
far outnumber neurons in the GI tract.  Morphologically, they resemble CNS astrocytes 
as they have irregular shapes and do not synthesize a basal lamina (14).  At the molecular 
level, enteric glia stain positively for both the neural crest marker S-100 and, in a fashion 
similar to astrocytes, glial fibrillary acidic protein (GFAP) (15-17) [Figure 1.4].  As no 
clear function could initially be linked to these cells, early investigators presumed that 
glia (from the Greek word meaning "glue") simply performed a supportive role in the 
gut—as they were once believed to behave in the brain and spinal cord.  Indeed, thre have 
been no published reports of electrophysiological studies of enteric glia to date.  
Nonetheless, the traditional notion that glia merely serve as passive or nutritive elements 
within the CNS and ENS is currently being challenged.   
Recent work in our laboratory has demonstrated that enteric glia, like CNS 
astrocytes, are functionally responsive to a variety of neuroligands (15,18-20).  The 
importance of glial cells in the ENS is underscored by the finding that their ablation in 
transgenic mice precipitates the onset of fatal fulminant jejuno-ileitis (21).  Other 




(e.g., endothelin receptor B—ET-B and RET proto-oncogene) (22-29) or their designated 
ligands (e.g., endothelin-3—ET-3 and glial derived neurotrophic factor—GDNF, 
respectively) (30-32), enteric glia may contribute in the pathogenesis of Hirschsprung's 
Disease—a congenital condition characterized by varying degrees of ENS 
maldevelopment and consequent intestinal dysfunction (for reviews see: 33-36).  
Collectively, these observations suggest that enteric glia may be active participants in 
ENS signaling and information processing, rather than simply supporting neurons within 
the continuously moving bowel wall.   
Even though enteric glia appear to have an essential role in the ENS, there is a 
paucity of literature characterizing the molecular mechanisms of signaling in these cells.  
To this end, we have sought to understand their role in information transfer in the GI tract 
by focusing upon an important component of signal transduction cascades: calcium 
signaling.  Our studies reveal that a number of compounds cause calcium signaling in 
enteric glia (15,18) [Table 1.1].  Members of this list include purines, peptides, and non-
purinergic/non-peptidergic compounds.  This research review will highlight 
representatives of two different classes of agonists with potent signaling effects in enteric 
glia: ATP (a purine) and endothelin (a peptide).   
 
Calcium Signaling 
The calcium ion (Ca2+) is a critical second messenger that serves to transduce 
extracellular signals into numerous intracellular events in a variety of cell types.  These 
functions range from short-term responses such as secretion, contraction, intercellular 




apoptosis (for reviews see: 37-50).  Glial intracellular Ca2+ levels are subject to intricate 
homeostatic mechanisms which achieve intracellular calcium concentrations ([Ca2+]i) that 
are roughly 40,000-fold lower than that of the extracellular environment.  Under control 
conditions, basal [Ca2+]i levels in enteric glia approximate 50 nM vs. 2 mM for 
extracellular calcium concentrations [Ca2+]e.  This steep electrochemical gradient favors 
Ca2+ entry.  The Ca2+ gradient is attributable to both the sequestration of Ca2+ into 
intracellular stores and mechanisms which export Ca2+ from within cells; these measures 
are accomplished by Ca2+/ATPase pumps in many cells, including CNS glia.  Glia are 
responsive to multiple stimuli which, in turn, initiate numerous downstream effects.  
Within the ENS a frequent consequence of glial cell stimulation is the generation of 
temporal and spatial elevations in their cytosolic Ca2+ levels—a response known as 
“calcium signaling”.   
Calcium signaling is achieved by a variety of mechanisms and culminates in 
either the influx of extracellular Ca2+ (Ca2+e) or the mobilization of internal Ca2+ (Ca2+i) 
pools.  Capacitative calcium entry (CCE) represents yet another aspect of Ca2+ signaling 
which incorporates both events. These concepts are discussed in greater detail in the 
following sections.  Each modality plays an integral role in Ca2+ signaling, rendering 
enteric glia capable of elevating [Ca2+]i levels into the micromolar range upon 
stimulation. 
 
Extracellular Calcium Influx 
There are two contexts in which Ca2+e plays a role in Ca2+ signaling.  The first 




cellular stimulation while the latter concerns a secondary, sustained response (i.e., CCE) 
to the initial release of Ca2+i stores.  Voltage-operated Ca2+ channels (VOCCs), ligand-
operated Ca2+ channels (LOCCs), and mechanosensitive Ca2+ channels (MSCCs) 
contribute to the initiation of cytoplasmic Ca2+ transients which utilize Ca2+e, whereas 
store-operated Ca2+ channels (SOCCs) play a role in CCE.  
VOCCs were originally considered to be components of “excitable cells” (e.g., 
neurons and skeletal or cardiac myocytes—cells which generate action potentials).  
However, experimental evidence now suggests that CNS glia possess VOCCs.  
Microfluorometric and electrophysiological approaches have revealed voltage-dependent 
Ca2+ currents in many types of cultured glia, including astrocytes (51-59).  Various glial 
cells also appear to possess ligand-operated Ca2+ channels.  Best studied of the LOCCs is 
the AMPA/KA family of ionotropic glutamate receptors (60-65).  NMDA receptors in 
glia are less well understood but remain an active topic of investigation (66,67).  
Receiving growing attention in glial cells are a unique group of Ca2+ channels which are 
activated upon mechanical stimulation.  The current knowledge of MSCCs is also 
limited, but investigation has been prompted by the observation that focal mechanical 
stimulation induces Ca2+ transients in individual glia and even causes intercellular 
signaling resulting in the propagation of Ca2+ waves in cultured cells (68).   
To date, functional VOCCs, LOCCs and MSCCs have not been firmly established 
in the enteric nervous system.  For this reason, our laboratory is interested in their 
potential involvement in enteric glia, which have many signaling mechanisms common to 





Intracellular Calcium Release 
The mechanisms leading to the release of Ca2+i stores have been intensively 
studied in many cells, including glia.  The general signal transduction cascade responsible 
for Ca2+i mobilization involves the initial activation of a metabotropic plasma membrane 
(PM) receptor (typically a G protein-coupled receptor but not infrequently a tyrosine 
kinase-linked receptor) and subsequent induction of phospholipase C (PLC), which 
generates the lipid-derived second messengers diacylglycerol (DAG) and 1,4,5-inositol 
trisphosphate (IP3) from phosphatidylinositol 4,5-bisphosphate (PIP2).  While DAG 
activates protein kinase C (PKC), IP3 causes Ca2+i release through its receptors which 
reside on the surface of the endoplasmic reticulum (ER) (for reviews see: 69-71).  The 
PLC-IP3 machinery appears intact and integral to calcium signaling in enteric glia since 
pharmacological inhibition of either PLC or the IP3 receptor selectively blocks Ca2+i 
transients in these cells (15,18).  Furthermore, the presence of IP3 receptors in enteric glia 
has been confirmed by immunofluorescent confocal microscopy (18) [Figure 1.5]. 
Recently, other intracellular organelles (e.g., mitochondria and the nucleus) have been 
purported to serve as participants in calcium signaling, but their role in enteric glia 
remains undefined. 
 
Capacitative Calcium Entry 
Capacitative Calcium Entry (CCE) refers to the process of Ca2+e influx as a direct 
consequence of the depletion of Ca2+i stores (72).   In the last several years, considerable 




The two principal questions surrounding CCE (also known as "store-operated calcium 
entry") are: 1) Which calcium channels are involved? and 2) What is the activating 
signal?  Boulay and colleagues showed in the past year that a mammalian homologue of 
Drosophila transient receptor potential channel proteins (i.e., human TRP3) may serve as 
the SOCC which permits Ca2+ entry in CCE (78).  Two major competing theories 
regarding the mechanism of CCE activation have been proposed; they are based upon 
either the involvement of a diffusible messenger (generically named "calcium influx 
factor" or CIF) (79,80) or the mechanical linkage of IP3 receptors to SOCCs through ER-
PM interactions (73,81).  Most current evidence favors the second scenario, though the 
mechanism has not been completely elucidated and both remain viable possibilities.  In 
the same investigation that established TRP3 as a SOCC candidate, Boulay et al. also 
provided compelling evidence that TRP channels are activated by a physical coupling 
with IP3 receptors.  This finding is consistent with the "secretion-like coupling model"—a 
concept proposed by Patterson et al. after discovering that ER-PM interactions are 
regulated by cytoskeletal modifications in such a manner that CCE, and not IP3-mediated 
store release, is selectively affected by F-actin redistribution (83). 
CCE has no established physiological function yet is believed to be an integral 
means of encoding biological cues by transforming acute Ca2+ signals into sustained 
transients.   
 
Recovery Following Calcium Signaling 
An important corollary to Ca2+e influx and Ca2+i mobilization is the vital role of 




extrusion.  The temporal nature of Ca2+ signals appears to be pertinent in the “coding” of 
messages and their ultimate termination seems obligatory for preventing initiation of 
apoptosis signals, which occur following sustained elevations in [Ca2+]i.  Ca2+ extrusion 
is chiefly accomplished by energy-dependent plasma membrane Ca2+-ATPases, which 
terminate calcium signals by re-establishing and maintaining low basal levels of [Ca2+]i.  
Similar mechanisms exist at the level of the ER for Ca2+i resequestration.  Experimental 
evidence for both recovery routes in enteric glia will be presented in this review in 
conjunction with the data depicting pre-recovery calcium signaling.   
Experimental Methods 
 
Myenteric Plexus Isolation 
 
Since our research focuses upon the enteric nervous system, we have utilized a 
model of dispersed, mixed primary cell cultures of enteric neurons and glial cells (15).  In 
brief, our technique involves the initial removal of taenia coli from the caecum of 
neonatal guinea pigs.  The taenia coli are then subjected to a collagenase incubation 
which facilitates microdissection and subsequent isolation of intact myenteric plexuses 
from within the separated circular and longitudinal muscle layers.  Following enzymatic 
digestion with trypsin, the plexuses are further mechanically dissociated by triturating 
with siliconized, flamed Pasteur pipets to produce a cell suspension.  The cells are 
cultured on collagen-coated coverslips in complete medium containing 5% New Serum I 





Intracellular Calcium Measurements 
 
After loading with the fluorescent calcium indicator fura 2-AM, cultured cells are 
examined using a Zeiss Axiovert inverted microscope and an Attofluor imaging system to 
determine single-cell intracellular Ca2+ concentration ([Ca2+]i).  [Ca2+]i is calculated from 
the ratios of the fluoroscence intensities of fura-2 at 334 and 380 nm, monitored by an 
intensified charge-couple device camera, and subsequently digitized.  Calibration of the 
system is performed with the two-point standardized equation, using fura-2-free acid: 
 
[Ca2+]i = Kd [(R-Rlow)/(Rhigh - R)]b 
 
where Kd is the dissociation constant of the Ca2+-fura 2 complex (225), R is F334/F380, i.e., 
the fluorescence at 334 nm excitation divided by the fluorescence at 380 nm excitation, 
Rlow is the ratio at zero Ca2+ (1 mM EGTA), Rhigh is the ratio at high Ca2+ (1 mM CaCl2), 
and b is F380 (zero Ca2+)/F380 (saturating Ca2+).  A ratio pair is taken at every 1.5-3.0 s.   
 
Purinergic Signaling in Enteric Glia—a Role for ATP 
Adenosine triphosphate (ATP) has long been appreciated as an important 
molecule in biological systems.  In addition to actions as an intracellular substrate for a 
vast array of enzymatic reactions, ATP also transduces signals through a family of cell-
surface purinergic receptors which were first identified in 1978 (83).  While the 
classification scheme has been modified through the years, the two main classes which 




(ATP/ADP).  A subclass of the P2 receptors (P2Y) are G protein-coupled—either 
partially through pertussis toxin (PTX)-sensitive G proteins (84) or exclusively through 
toxin-insensitive G proteins (85).  Of these, the P2Y2 (formerly known as P2U) receptor 
has been cloned and localized to a number of normal and transformed cells including the 
C6 glioma cell line which has been extensively studied as a model of glial cells (84-87).   
Our studies have shown that enteric glia undergo robust Ca2+ signaling following 
exposure to purinergic compounds (15) [Figure 1.6].  Given the agonist profile ATP = 
UTP > ADP > β,γ-methyl-eneadenosine 5’-triphosphate >> 2-methylthioadenosine 5’-
triphosphate = AMP = adenosine, we concluded that enteric glia possess a P2Y2 receptor 
and that the ATP-induced signal was due to stimulation of this receptor.   
The Ca2+ signaling induced by ATP was dose-dependent over a range of 0.5 to 
1000 μM [Figure 1.7].  Additionally, this response was attenuated with repetitive 
exposure, suggesting that it was a receptor-mediated event.  Further evidence in support 
of this being a receptor-mediated event include the findings that Ca2+ responses were 
decreased 92% by U-73122, an inhibitor of PLC, and 93% by the phorbol ester phorbol 
12-myristate 13-acetate (PMA), an activator of PKC.  Additionally, depletion of IP3-
sensitive Ca2+ stores by the ER Ca2+-ATPase pump inhibitor thapsigargin abolished glial 
responses to ATP.  Pertussis toxin (100 ng/ml, 24 h) did not alter ATP-induced Ca2+ 
signals, indicating that a G protein of the Gi subtype is not involved in this response.   
These data imply that glial responses to ATP are mediated by a PTX-insensitive 
P2Y2 receptor coupled to activation of phospholipase C and release of Ca2+i stores.  




functionally responsive to a variety of neurotransmitters, in addition to ATP, including 
serotonin, bradykinin, histamine. 
 
Peptidergic Signaling in Enteric Glia—a Role for Endothelin 
The endothelins are a family of 21-amino acid isopeptides (ET-1, ET-2, ET-3) 
that were initially linked to vasoreactivity modulation.  Two endothelin receptor subtypes 
(ETA and ETB) have been cloned; these receptors have been shown to couple either to 
PTX-sensitive or PTX-insensitive regulatory G proteins (89).  Although endothelins were 
initially associated with the regulation of cardiovascular function, the identification of 
endothelin receptors in a variety of other tissues suggests a more heterogeneous array of 
actions may exist (89).  Within the GI tract, endothelins have been reported to influence 
acetycholine-induced intestinal contractility, colonic secretion, and development of the 
ENS (90-92,30).  Targeted disruption of either the ETB receptor or its ligand ET-3 results 
in aganglionic megacolon in animals (23,24,30); corresponding genetic mutations are 
also found patients with Hirschsprung’s disease (22,31).  These findings suggest a role 
for endothelin in the regulation of gastrointestinal function; the involved mechanisms are 
not completely known. 
We have recently reported that each endothelin isoform (ET-1, ET-2, and ET-3) 
evoked dose-dependent and equipotent increases in [Ca2+]i (18) [Figures 1.8, 1.9].  
Responses to endothelin were inhibited by BQ-788, an ETB antagonist.  Sustained 
elevation in [Ca2+]i was abolished by removal of Ca2+ from the buffer, inhibited 85% by 
Ni2+, and diminished by preincubation of glia with PMA by 87%.  U-73122 pretreatment 




thapsigargin   Following introduction of the IP3 receptor antagonist heparin by 
radiofrequency electroporation, responses to ET-3 were attenuated by 63% in enteric glia 
[Figure 1.10].  Preincubation of enteric glia with 100 nM PTX for 24 h failed to inhibit 
[Ca2+]i changes in response to 100 nM ET-3.   
These data suggest that enteric glia possess the capability of responding to ET 
with Ca2+ signaling via a mechanism involving intracellular and extracellular Ca2+.  The 
events are initiated by a PTX-insensitive ETB receptor which causes Ca2+i release through 
PLC and subsequent activation of the IP3 receptor and also facilitates Ca2+e influx via 
Ni2+-sensitive PM Ca2+ channels. 
 
Capacitative Calcium Entry in Enteric Glia—Effects of ATP and Endothelin 
 
Our investigations have also revealed that in addition to causing Ca2+ signaling 
through Ca2+i release, ATP and ET [Figure 1.11a] similarly activate CCE in enteric glia 
(19,20).  When ET was used as an agonist, these responses were blocked by Ni2+ (89%) 
and La3+ (78%)—both inorganic, nonspecific inhibitors of Ca2+ channels [Figures 1.11b-
1.11d].  Similar results were obtained using ATP.  In contrast, neither diltiazem nor ω-
conotoxin had any inhibitory effect, suggesting that L-type and N-type Ca2+ channels, 
respectively, were not involved in these responses.  Chelerythrine, a specific antagonist 
of PKC, and the nitric oxide synthase inhibitor NG-nitro-L-arginine also diminished CCE 
in response to either agonist.   
These data indicate that ATP and ET cause CCE in enteric glial cells via non-L 





In summary, enteric glia appear to be more than mere passive elements within the 
enteric nervous system.  Rather, our data illustrate that they are responsive to an array of 
signaling molecules.  ATP and endothelin are two such agonists which cause calcium 
signaling via cascades incorporating PTX-insensitive plasma membrane receptors (P2Y2 
and ETB, respectively) and PLC activation [Figure 1.12].  In addition to mobilizing 
intracellular calcium stores, ATP and ET also initiate the subsequent influx of 
extracellular calcium—capacitative calcium entry.  While the physiological role of these 
signal transduction cascades remains unclear, given the observations made thus far by our 
lab and others it is tempting to speculate that enteric glia play an active role in 
















Figure 1.1.  Plexuses of the enteric nervous system.  Schematic drawing of the wall of 
the intestine showing the layers which must be removed by microdissection in order to 


















Figure 1.2.  Myenteric plexus isolated from neonatal guinea pig taenia coli.  Plexus 
shown was dissected following overnight incubation in collagenase at 4oC and 




















Figure 1.3.  Dispersed primary culture of neonatal guinea pig myenteric plexus 
depicting enteric neurons (N) and glia (G).  Cells shown at day 5 in culture.  Note 





















Figure 1.4.  Immunofluorescence staining of GFAP & S-100 in enteric glia.  Neonatal 
guinea pig myenteric plexus cultures from days 2-4 in vitro were incubated with anti-
GFAP (primary) and goat anti-mouse fluorescein isothiocyanate fragment (secondary) or 
anti-S-100 (primary) and streptavidin-Texas red (secondary).  Glia stained positively for 












































Compound   Responding Cells (Dose) Reference 
      
ATP    100% (100 μM)  15 
UTP    100% (100 μM)  15 
ADP    15% (100 μM)  15 
βγ-MeATP   7% (100 μM)   15 
Serotonin   4% (100 μM)   15 
Bradykinin   11% (10 μM)   15 
Histamine   31% (100 μM)  15 
Endothelin-1   100% (1 nM)    18 
Endothelin-2   100% (1 nM)    18 
















Figure 1.5.  Immunofluorescence staining of intracellular inositol 1,4,5-
trisphosphate (IP3) receptors in enteric glia.  Neonatal guinea pig myenteric plexus 
cultures at day 3-5 in vitro demonstrate coexistence of IP3 receptor (fluorescein 
isothiocyanate, A and C) and S-100 (rhodamine, B and D) in the same cells.  No staining 


















Figure 1.6.  ATP-induced Ca2+ signaling.  Typical enteric glial response to ATP 
superfusion (100 μM, 250 s) in a calcium-containing buffer.  KCl superfusion (55 mM, 
60 s) does not increase [Ca2+]i in enteric glia; this lack of response in addition to 


















Figure 1.7.  Concentration-dependent increases in peak [Ca2+]i evoked by ATP in 


















Figure 1.8.  Endothelin (ET)-induced Ca2+ signaling.  Typical enteric glial responses 
to superfusion of ET-3 (60 s).  A. 0.1 nM ET-3 caused only a transient increase in [Ca2+]i.  



















Figure 1.9.  Concentration-dependent Ca2+ signaling by ET isotypes 1,2,3.  ET-1, ET-
2, ET-3 cause dose-dependent increments in peak [Ca2+]i (A) and in percentage of cells 























Figure 1.10.   ET-3 mobilizes IP3 receptor stores.  Intracellular heparin, an IP3R 
antagonist, inhibited ET-3 evoked increases in [Ca2+]i in enteric glia.  A. Fluorescence 
image of glia taken at 380 nm.  Arrows identify position of platinum wire electrodes.  B. 
An image of glia in the same field, viewed under 560 nm wavelength.  A loading border, 
marked by Texas red, identifies electroporated cells (left).  C. Pseudocolor image of cells 
under basal conditions.  Both electroporated and non-electroporated cells loaded with 
fura 2 and maintained similar basal [Ca2+]i levels.  D. On exposure to 100 nM ET-3, glia 
containing heparin did not demonstrate increases in [Ca2+]i; non-electroporated cells in 
the same field (right) responded rapidly to ET-3 exposure.  Electroporation of chondroitin 
sulfate, which approximates the size and charge of heparin, had no effect on ET-3 


















Figure 1.11.   ET-3 causes capacitative calcium entry (CCE).  A. Depletion of 
intracellular Ca2+ stores by 10 nM ET-3 in Ca2+-free buffer causes subsequent CCE on 
addition of Ca2+ to the perfusion buffer.  B. Superfusion with 1 mM Ni2+ inhibited the 
increase of [Ca2+]i when Ca2+ was added to the perfusion buffer; [Ca2+]i increased when 
Ni2+ was removed.  C. Similar to Ni2+, La3+ reversibly inhibited CCE.  D. Summary of 



































Figure 1.12.  Summary model of ATP- and ET-induced Ca2+ signaling in enteric 
glia.  CCE=Capacitative Calcium Entry, ER=endoplasmic reticulum, IP3=1,4,5-inositol 
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SPHINGOSINE-1-PHOSPHATE AND RELATED BIOACTIVE LIPIDS 
SELECTIVELY MEDIATE CALCIUM SIGNALING IN GLIAL CELLS OF THE 
ENTERIC NERVOUS SYSTEM 
 
 
[Note:  This chapter has been slightly modified from a published manuscript: Segura, 
B.J., Zhang, W., Xiao, L., Turner, D., Cowles, R.A., Logsdon, C., & Mulholland, M.W. 
2004. Sphingosine-1-phosphate mediates calcium signaling in guinea pig enteroglial 





The enteric nervous system (ENS) regulates the gastrointestinal tract.  Within this 
intricate network, enteric glia play a crucial role in maintaining normal bowel integrity, 
yet their signaling mechanisms are only beginning to be understood.  We studied the 
actions of a novel lipid compound in the ENS with the long-term goal of understanding 
neurotransmission within the gut.  Here we report that enteric glia, and not enteric 
neurons, respond to a unique class of molecules: bioactive lipids.  Of these, the 




(Ca2+) signaling utilizing extracellular and intracellular Ca2+.  Although pertussis toxin-
insensitive, this signal transduction cascade appears to involve an extracellular receptor 
since repetitive exposure yields diminished responsiveness and inhibition of either 
phospholipase C or the inositol 1,4,5-trisphosphate receptor abolishes S1P effects.  
Further supporting a receptor-mediated event, RT-PCR analysis demonstrates the 
presence of several S1P-coupled endothelial differentiation gene (EDG) receptor mRNAs 
(EDG-1, EDG-3, and EDG-5) within the ENS.  Immunocytochemical analysis 
demonstrated strong expression of both EDG-1 and EDG-3 and weak expression of 
EDG-5 in enteric glial cells.  As other sphingomyelin cycle components (sphingomyelin, 
sphingomyelinase, and sphingosine) also activate Ca2+ signaling in enteric glia, we 
postulate that these cells are capable of processing sphingolipids to elicit intracellular S1P 
responses.  Additionally, the finding that related lipids lysophosphatidic acid and 
sphingosylphosphorylcholine—agonists of differing EDG receptors—also induce Ca2+ 
signaling in enteric glia suggests multiple lipid-activated signaling mechanisms exist in 
these cells.  We propose that S1P and other bioactive lipids function as novel signaling 






The enteric nervous system (ENS) is the largest division of the peripheral nervous 
system, and modulates virtually all aspects of gastrointestinal (GI) function, including 
blood flow, secretion, absorption, and motility (1).  Within the ENS, glial cells far 
outnumber neurons and are similar to astrocytes of the central nervous system (CNS) at 
morphological and molecular levels (2-4).  The traditional notion that glia merely serve 
as passive or nutritive elements within the CNS and ENS is currently being challenged 
(5).  Recent studies have revealed that enteric glia, like CNS astrocytes, are functionally 
responsive to a variety of neuroligands (6-9).  The importance of glial cells in the ENS is 
further substantiated by the finding that adult transgenic mice develop fulminating and 
fatal jejuno-ileitis following ablation of enteric glia (10).  Additional investigations 
indicate that, as a consequence of abnormalities in endogenous ENS receptors (11-18) or 
their designated ligands (12, 19-21), enteric glia may contribute in the pathogenesis of 
Hirschsprung’s disease.  These observations collectively suggest that enteric glia play an 
active role in ENS signaling and information processing to preserve normal GI function, 
rather than simply supporting neurons within the continuously moving bowel wall.   
Sphingosine-1-phosphate (S1P) has received increasing attention as a member of 
a new class of lipid signaling molecules (22).  S1P is generated through sphingomyelin 
catabolism and has been implicated in an array of cellular events including calcium 
(Ca2+) signaling (5, 23, 24). S1P is distinctive because it may serve as both an 
intracellular and an extracellular mediator of Ca2+ mobilization (25- 30).  The recent 




sparked interest in the role of this lipid as an extracellular messenger (23, 27, 28, 31-34).  
A role for S1P and other bioactive lipids in the ENS has not been established. 
Enteric glia were postulated to be responsive to sphingolipids and the mechanisms 
by which S1P affects intracellular Ca2+ concentration ([Ca2+]i) were examined in these 
cells. The current studies demonstrate that in enteric glia: 1) numerous sphingomyelin 
cycle components and related lipids selectively cause calcium signaling; 2) S1P elicits 
dose-dependent Ca2+ signaling in the percentage of responding cells and in the 
incremental rise in [Ca2+]i; 3) S1P-induced Ca2+ responses desensitize with repetitive 
exposure; 4) S1P effects are not inhibited by pertussis toxin exposure; and 5) S1P 
mobilizes thapsigargin- and inositol-1,4,5-trisphosphate-sensitive intracellular Ca2+ stores 
through activation of phospholipase C.  Myenteric plexus cultures were demonstrated to 
express EDG-1, EDG-3 and EDG-5 receptor mRNA, and to be positive 
immunocytochemically for EDG-1, EDG-3 and, to a lesser degree, EDG-5.   
 
Experimental Methods 
Materials and Reagents 
 
Sphingosine-1-phosphate (S1P), D-erythro-sphingosine (D-SPH), L-erythro-
sphingosine (L-SPH), lysophosphatidic acid (LPA), sphingosylphosphorylcholine (SPC), 
sphingomyelin (SM), sphingomyelinase (SMase), adenosine triphosphate (ATP), 
collagenase type V, thapsigargin, U73122, U73343, trypsin-EDTA, soybean trypsin 
inhibitor (type I-S), penicillin-streptomycin solution, N-2-hydroxyethylpiperazine-N’-2-




C2-ceramide (C2-CER) was from Cayman Chemical (Ann Arbor, MI).  Pertussis toxin 
(PTX) was from Calbiochem (San Diego, CA).  Hanks’ balanced salt solution (HBSS), 
medium 199, and L-glutamine were from GIBCO BRL (Grand Island, NY).  Rat tail 
collagen was from Boehringer Mannheim (Mannheim, Germany).  New Serum I (NSI) 
was from Collaborative Research (Bedford, MA).  2-aminoethoxydiphenyl borate (2-
APB) was from Tocris (Ballwin, MO).  Fura-2-AM, fluorescein conjugated streptavidin 
(S-869), DAPI cytological nuclear conterstain kit (C-7590) and prolong antifade kit (p-
7481) were from Molecular Probes, Inc. (Eugene, OR).   TRIzol reagent, DNAse I, 
SuperScript II RNase H- Reverse Transcriptase (RT), and RT buffer were from Life 
Technologies, Inc. (Grand Island, NY).  Deoxynucleotides (dNTP mix) and oligo d(T) 
primers were from Roche Molecular Biochemicals (Indianapolis, IN).  RNase inhibitor 
was from Promega (Madison, WI).  Advantage cDNA polymerase mix and PCR reaction 
buffer were from Clontech Laboratories, Inc. (Palo Alto, CA).  One-day-old male 
Duncan-Hartley guinea pigs were obtained from Simonsen Labs (Gilroy, CA).   
EDG1 C-terminus rabbit polyclonal antibody (Ab) (X1093P), EDG1 blocking 
peptide (X1224B),  EDG3 N-terminus mouse monoclonal Ab (C175M) and EDG5 C-
terminus mouse monoclonal Ab (C190M) were from Exalpha Biologicals, Inc. 
(Boston,MA).  Normal goat serum (sc-2043), biotinylated goat anti-mouse IgG (sc-2039) 
and biotinylated goat anti-rabbit IgG (sc-2040) were from Santa Cruz Biotechnology, 





Myenteric Plexus Isolation 
 
Dispersed primary cultures of guinea pig myenteric plexus were prepared on 
collagen-coated coverslips and used for experiments within 10 days post-plating using a 
protocol refined in our laboratory (6).  One- to three-day-old Duncan Hartley guinea pigs 
were sacrificed and their taenia coli were removed using sharp dissection with tissue 
forceps and Castro-Viejo scissors then placed in Hanks Balanced Salt Solution 
supplemented with 0.1% Type IV collagenase for 16-24 h at 4oC.  After a 30-60 minute 
incubation at 37oC, the muscle layers of the taenia coli were separated from the myenteric 
plexus with the use of fine tissue forceps and a dissecting microscope.  The myenteric 
plexus was trypsinized for 30 min at 37oC using 0.1% trypsin-EDTA solution, triturated 
with siliconized flamed Pasteur pipettes of decreasing diameter, and plated on 
aseptically-prepared collagen-coated 22 mm glass coverslips in a 35 mm culture dish 
using sterile technique.  Cultures were exposed to complete medium 199 plus 5% NSI 
and 0.01% trypsin inhibitor.  Penicillin-streptomycin solution was added for the first 48 h 
at a 2% concentration.  Antimitotic agents were not added.  Medium was changed every 
24-36 hours.  The cultures were incubated at 37oC with 5% CO2.  All animals were used 
in accordance with established guidelines and protocols approved by the University 
Committee on the Use and Care of Animals at the University of Michigan Medical 







All experiments were performed in standardized solutions except when noted.  
Standard control buffer was a modified Krebs-Ringer solution at pH 7.40 containing (in 
mM) 118 NaCl, 4.7 KCl, 1.8 CaCl2, 10 HEPES, 15 NaHCO3, 11 glucose, 0.9 NaH2PO4, 
and 0.8 MgSO4.  In Ca2+-free control buffer, the CaCl2 was omitted and 0.5 mM EGTA 
was added.   
 
Loading and Cell Preparation for Imaging 
 
For loading purposes, fura 2-AM was added to achieve a final concentration of  2 
μM for 45 min to cultured myenteric plexus and incubated at 370C in serum-containing 
growth media described above that was changed no less than 24 hours prior to avoid 
acute effects of new serum supplementation.  Loaded coverslips were washed and then 
stored in serum-free control buffer and placed in a lucite superfusion chamber 
(approximate volume 0.5 ml).  The superfusion rate of the control buffer and 




A Zeiss Axiovert inverted microscope and an Attofluor imaging system 
(Rockville, MD) were used to determine single-cell intracellular Ca2+ concentration 




334 and 380 nm, monitored by an intensified charge-couple device camera, and 
subsequently digitized.  Calibration of the system was performed with the two-point 
standardized equation, using fura-2-free acid: 
 
[Ca2+]i = Kd [(R-Rlow)/(Rhigh - R)]b 
 
where Kd is the dissociation constant of the Ca2+-fura 2 complex (225), R is F334/F380, i.e., 
the fluorescence at 334 nm excitation divided by the fluorescence at 380 nm excitation, 
Rlow is the ratio at zero Ca2+ (1 mM EGTA), Rhigh is the ratio at high Ca2+ (1 mM CaCl2), 
and b is F380 (zero Ca2+)/F380 (saturating Ca2+).  Frames were not averaged to obtain 
images.  The system was used to obtain whole field images.  Boxes were placed on all 
cells of interest for simultaneous measurement of intracellular Ca2+ concentration 
([Ca2+]i).  A ratio pair was taken at every 1.5-3.0 s.   
 
RNA Extraction and Reverse Ttranscription (RT) 
 
Total cellular RNA was isolated from 5 day-old myenteric plexus primary cell 
cultures using TRIzol reagent according to manufacturer’s directions.  Single strand 
cDNA synthesis was performed as follows: 20 µl of reverse transcription mixture 
contained 1 µg of DNase I pre-treated total RNA, 0.5 µg of oligo d(T) primer, 4 µl of 5 x 
RT buffer, 10 mM dithiothreitol, 0.5 mM deoxynucleotides, 40 units of RNase inhibitor, 
and 200 units of reverse transcriptase (SuperScript II RT).  The RT reaction was carried 




Polymerase Chain Reaction (PCR) 
 
50 μL of PCR reaction mixture contained 1 µl of RT products, 1X cDNA PCR 
reaction buffer, 400 nM of each primer, 200 µM of dNTP mix, and 1X Advantage cDNA 
polymerase mix.  The PCR was carried out using a Perkin-Elmer Thermal Cycler 
(Norwalk, CT).  Samples were denatured initially at 94oC for 1 min and the PCR was 
performed as follows: 38 cycles of 35 sec at 94oC, 1 min at 62oC and 1 min 40 sec at 
72oC for EDG-1; 38 cycles of 35 sec at 94oC, 1 min at 67oC and 1 min 20 sec at 72oC for 
EDG-3; 38 cycles of 35 sec at 94oC, 2 min 15 sec at 68oC for EDG-5, following by the 
final extension at 72oC for 7 min. 
PCR primers used for guinea pig mRNA detection were deduced from human, 
mouse and rat published sequences. The nucleotide sequences of sense and antisense 
primers with the expected product size are follows: EDG-1, TAT GAT ATC ATA GTC 
CGG CAT TAC A (sense) and GCA TCT CCT TGT TGG TCA GAG TGT (antisense) 
(892 bp product); EDG-3, CTC AGG GAG GGC AGT ATG TTC GT (sense) and TCC 
TTG ACC TTC GGA GAG TGG CTG (antisense) (715 bp product); EDG-5, GAA CAC 
TAC AAT TAC ACC AAG GAG ACG C (sense) and ACG ATG GTG ACC GTC TTG 
AGC AGG GC (antisense) (667 bp product).  For negative controls, PCR reactions were 






Sequencing and Data Analysis 
 
PCR products were electrophoretically analyzed on 1.5% agarose gel containing 
ethidium bromide.  DNA bands were excised from the gel and purified as follows: gel 
slices were crushed in the tube and sample DNA was extracted twice with buffered 
phenol and once with phenol:chloroform:isoamyl (25:24:1) followed by ethanol 
precipitation with 0.1  volume of 3M sodium acetate (pH 5.2) and 2.5 volume of 100% 
ethanol and washing with 70% ethanol.  The purified DNA fragments were directly 
sequenced by the DNA sequencing core at the University of Michigan using Applied 




Cultured guinea pig myenteric plexus cells were used on day 5 or day 6.  Cells 
were fixed in freshly prepared 4% paraformaldehyde/PBS (pH 7.4) for 20 min at 4O C (all 
steps were performed at 4oC unless otherwise noted.  Following rinsing in PBS, the cells 
were incubated with blocking/permeabilization buffer (10% normal goat serum, 2% BSA 
and 0.1% saponin in PBS) for 20 min at room temperature.  After washing with PBS, the 
cells were incubated with primary antibody solution overnight at 4oC.  Mouse 
monoclonal antibody was diluted at 1:50 in PBS with 1.5% goat serum.  Rabbit 
polyclonal antibody was diluted at 1:100 in PBS with 1.5% goat serum.   As a negative 
control, rabbit polyclonal antibodies were pre-incubated with specific blocking peptides 
for 20 min at 37O C; the sample without primary antibody was used for negative control 




were incubated for 45 min with biotinylated goat anti-mouse or anti-rabbit antibody 
(1:200 diluted in PBS with 1.5% goat serum), illuminated by reaction with fluorescein 
conjugated streptavidin, stained with DAPI cytological nuclear conterstain kit and 
mounted with prolong antifade kit following company instructions.  Samples were 
examined using a Nikon microscope with epifluorescence capabilities and images were 
recorded using a Spot camera then processed in Adobe photoshop. 
 
Data Presentation and Calculation 
 
Results are expressed as mean ± SEM.  Data were analyzed using an unpaired 
Student’s t-test.  Significance was accepted as P < 0.05 (95% confidence interval).   
Dissection techniques, tissue preparation, media, and reagent vendors remained 
constant throughout the study.  In this study, n equals the number of glial cells examined.  
At least three coverslips were used for each experimental condition.  All experimental 
conditions were examined on glial cells derived from cell preparations performed on at 
least two different days.   
Results have been calculated only from those responding glia having basal [Ca2+]i 
levels < 100 nM, a criteria met by > 95% of glial cells.  Cells were considered to be 
responsive if peak [Ca2+]i was at least 50 nM higher than the baseline value.  Glia with a 
high [Ca2+]i before any addition of agonist were considered damaged or leaky and were 
excluded from the study.  Only one microscope field was examined per coverslip.  Peak 
[Ca2+]i was measured as the highest [Ca2+]i achieved during agonist exposure.  Δ[Ca2+]i 




At the time of the experiments, two criteria were used to determine whether cells 
of interest were glial cells, as opposed to neurons.  1) Morphology.  Myenteric neurons 2-
7 days post-plating are compact and phase-bright, with few or no processes.  Enteric glia 
have a larger, dense nucleus with wide surrounding cytoplasm.  2) KCl depolarization.  
At the end of each experiment, the coverslip was superfused with 55 mM KCl.  Enteric 
glia typically do not exhibit increments in [Ca2+]i on exposure to 55 mM KCl.  
 
Experimental Results  
 
Sphingolipid Analogs Cause Ca2+ Signaling in Enteric Glia.   
 
To determine whether cultured guinea pig enteric glial cells are responsive to 
bioactive lipids, mixed primary cultures of myenteric plexus were exposed to an array of 
related lipid compounds that are depicted in a summary of the biochemical metabolism of 
sphingomyelin (SM) [Figure 2.1].  The compiled data of these bioactive lipids and other 
components of the SM cycle are displayed in Figure 2.2.  Perfusion of glial cells with SM 
(1 μM) for 300 s caused Ca2+ mobilization in 5±6% of glial cells (n=119).  Exposure of 
cells to SMase for 300 s (0.1 U/ml) produced increments in [Ca2+]i in 48±31% of cells 
(n=109), suggesting that enzymatic generation of sphingolipid signaling molecules can 
elicit calcium signaling.  C2-CER (1 μM and 10 μM), a truncated form of ceramide that 
retains biological activity yet is less likely than full length ceramide to be further 
metabolized, did not produce increases in [Ca2+]i within five minutes of exposure (96 and 




increments of 108±4 nM with 28±9% of cells responding (150 cells examined).  For 
control of non-specific effects, an inactive enantiomer of sphingosine, L-SPH (10 μM), 
was also investigated.  L-SPH did not induce Ca2+ signaling in any of the cells examined 
(n=184).  S1P (1 μM) superfusion produced Ca2+ transients [Figure 2.3] in 80±14% of 
cells (Δ[Ca2+]i=203±10 nM; n=143) examined over 300 seconds.  LPA (1 μM) and SPC 
(1 μM) also generated Ca2+ signals of 141±5 nM and 161±9 nM in 85±6% (n=114) and 
66±20% (n=128) of enteric glia, respectively.  Enteric neurons were not found to respond 
with Ca2+ signaling to any of the lipids investigated, including S1P [Figure 2.4].  Further 
suggestive of neuronal-independent signaling by S1P, pre-treatment with the depolarizing 
agent tetrodotoxin (1 μM) for ten minutes had no effect upon S1P transients. 
 
S1P-mediated Ca2+ Signaling  is Dose-Dependent and Desensitizes with Repetitive 
Exposure.   
 
S1P produced dose-dependent increments in percentage of cells responding 
[Figure 2.5a] and in [Ca2+]i increments [Figure 2.5b] over the range of 1 nM to 10 μM.  
For remaining experiments, 1 μM S1P was chosen as a suitable working dose.  Repetitive 
exposure to S1P produced progressive decrements in peak [Ca2+]i in enteric glia [Figure 
2.6a].  An approximately 31% decrease in peak [Ca2+]i responses was observed between 
first and second S1P exposures, and another decrement of 16% between the second and 
third exposures [Figure 2.6b].  88±6% of cells responded to S1P and none completely 




intracellular Ca2+ stores, cells were subsequently perfused with ATP (100 μM) at the end 
of each experiment and significant increments in [Ca2+]i were achieved.  
 
S1P Responses are Pertussis Toxin (PTX)-Insensitive.   
 
To investigate the involvement of a PTX-sensitive G protein, enteric glia were 
preincubated with PTX at 100 ng/ml for 24 h, a concentration and preincubation time 
found to be inhibitory in other studies (35, 36).  Δ [Ca2+]i generated by S1P in glia pre-
exposed to PTX was 137±7 nM (n=133), relative to the Δ [Ca2+]i evoked in control glia 
of 151±7 nM (n=153).  The percentage of cells responding to S1P was also similar in 
these two groups:  81±3% vs. 82±3% for PTX-treated and non PTX-treated cells, 
respectively.   
 
S1P Mobilizes Intracellular Ca2+ Stores.   
 
To evaluate the role of intracellular Ca2+ (Ca2+i) stores in S1P-generated calcium 
signaling, responsiveness of enteric glia to S1P was investigated using Ca2+-free medium 
supplemented with 1 mM EGTA.  Exposure to S1P in a nominally Ca2+-free medium had 
no effect on percentage of cells responding or on peak [Ca2+]i , suggesting that the initial 
Ca2+ response is generated from Ca2+i stores.  The morphology of the observed Ca2+ 
transients, however, were distinctly different [Figure 2.7].  The absence of extracellular 
Ca2+ (Ca2+e) abolished the sustained plateau in intracellular [Ca2+], indicating that an 




the endoplasmic reticulum Ca2+-ATPase, depletes Ca2+i stores without generating IP3.  
During superfusion with thapsigargin (1 μM) in a Ca2+-free medium, all cells (n=123) 
responded with increases in [Ca2+]i, followed by return of [Ca2+]i to baseline; at this 
point, Ca2+i stores were presumed to be depleted.  Subsequent exposure to S1P produced 
Ca2+ transients in none of the glial cells examined [Figure 2.8].   
 
S1P Activates Phospholipase C (PLC).   
 
The aminosteroid U-73122 has been shown to inhibit PLC-coupled responses in a 
variety of cells.  Pretreatment of myenteric glia with U-73122 (1 μM) for 300 s abolished 
subsequent S1P-induced Ca2+ signaling (5±4% of experimental cells responding vs. 
89±5% for control cells) [Figure 2.9; n=171 and 145, respectively].  The inactive 
analogue of U-73122 (U-73343, 1 μM) had no effect on S1P-mediated Ca2+ transients 
[Figure 2.9; n=170], suggesting the effect of U-73122 was not due to nonspecific 
cytoxicity. 
 
S1P-induced Ca2+i Mobilization Involves the Inositol 1,4,5-trisphosphate (IP3) 
Receptor (IP3R).   
 
The role of IP3-sensitive intracellular Ca2+ stores in S1P signaling was 
investigated using the membrane-permeable IP3R antagonist 2APB.  2APB has been 
utilized in a variety of cell types to reversibly modulate IP3R activity independent of IP3 




stores (37, 38).  In this investigation, 2APB had no effect on basal cytosolic [Ca2+] at any 
of the doses evaluated.  2APB caused dose-dependent inhibition of S1P-induced Ca2+ 
signals in enteric glia, nearly abolishing responsiveness at a concentration of 200 μM 
[Figure 2.10].  Following pretreatment with 2APB (200 μM X 5 min), only 6±6% of glia 
(n=161) responded to S1P exposure vs. 92±3% for controls (n=156).  
 
 
EDG-1, EDG-3 and EDG-5 mRNAs are Expressed in the ENS.   
 
To further assess the participation of S1P-responsive G protein-coupled receptors 
of the endothelial differentiation gene family, RT-PCR analysis was performed using 
primers generated from known human and rodent coding sequences.  Five-day old mixed 
primary cultures from guinea pig myenteric plexus express mRNA corresponding to 
EDG-1, EDG-3, and EDG-5 [Figure 2.11].  Sequence analysis indicates that these three 
mRNAs in the guinea pig have a high degree of homology with known nucleotide and 
amino sequences from human, rat, and mouse [Table 2.1].  Neither EDG-6 nor EDG-8 
mRNA were found to be expressed in ENS cultures, yet it remains a possibility that our 
primers were not of sufficient precision as they were based on incomplete sequence data 





EDG-1 and EDG-3 Expression by Immunocytochemistry 
 
In earlier work,  we demonstrated that cells with distinct glial morphology stain 
positively immunocytochemically for glial fibrillary acidic protein and S-100, specific 
markers for glia, while staining negatively for fibronectin (fibroblasts) or neuron-specific 
enolase or MAP2 (neurons) (6).  In this investigation, enteric glial cells stained intensely 




The present study demonstrates that myenteric glia possess the necessary 
signaling processes for transducing responses to a novel class of signaling molecules—
sphingolipids.  The data supporting this conclusion are four-fold:  1) multiple 
components of the sphingomyelin cycle (sphingomyelin, sphingomyelinase, sphingosine 
and sphingosine-1-phosphate) and the related lysosphingolipids and lysoglycerolipids 
(sphingosylphosphorylcholine and lysophosphatidic acid, respectively) selectively cause 
calcium signaling in primary cultures of enteric glia; 2) S1P–induced Ca2+ signaling is 
dose-dependent with respect to both the percentage of responding cells and the 
incremental rise in [Ca2+]i;  3) responsiveness to S1P desensitizes following repetitive 
exposure; and 4) S1P acts via a PTX-insensitive mechanism to activate PLC and mobilize 
thapsigargin- and IP3-sensitive intracellular Ca2+ stores, precipitating the influx of 
extracellular calcium. RT-PCR analysis reveals that cultured cells of the guinea pig 
myenteric plexus express three members of a new family of sphingolipid-responsive G 




suggests that all three EDG receptors are expressed in myenteric cultures although EDG-




 Recent evidence suggests that enteric glia play an active role within the enteric 
nervous system.  Previous reports have shown that enteric glia, like astrocytes of the 
CNS, undergo Ca2+ signaling in response to a variety of neuropeptides and to purinergic 
compounds such as ATP (6-9).  The potential involvement of sphingomyelin-derived 
lipid compounds as signaling molecules within the ENS suggests that non-purinergic, 
non-peptidergic mechanisms may also act to modulate glial activity within the myenteric 
plexus.  The finding that S1P is a potent agonist for Ca2+ signaling in enteric glial cells, 
and that a variety of other sphingomyelin metabolites and related lipids also have 
selective effects in these cells, implies that there may be multiple mechanisms for lipid 
signaling in the ENS.   
Sphingolipid metabolites such as S1P and its receptors have recently been shown 
to affect a wide variety of biological processes including cellular proliferation, migration 
and development (30, 39-49), neurite retraction (50, 51), and neuronal survival and 
differentiation (52).  S1P causes Ca2+ signaling in cultured CNS astrocytes and Ca2+ 
transients and shape changes in C6 glioma cells (24).  There is no established role for 
sphingolipids within the enteric nervous system.  This study provides the first evidence 
for sphingolipid signaling in cultured enteric glial cells, which share many morphological 




A common feature of many studies of S1P is the ability of this compound to 
increase intracellular calcium levels.  Two general models have been proposed for Ca2+ 
signals generated by S1P:  1) direct release of Ca2+i stores due to interaction between the 
lipid and internal Ca2+ pools, and 2) increases in [Ca2+]i as a consequence of a plasma 
membrane-mediated signaling event (23).  This investigation offers strong support for the 
second mechanism in enteric glial cells.   
Goodemote et al. (53) initially observed that S1P effects in Swiss 3T3 fibroblasts 
were pertussis toxin sensitive, suggesting this lipid possessed activity that resembled 
other agonists of G-protein-coupled receptors (GPCRs).  The recent characterization of a 
family of GPCRs (EDG receptors) with affinity for S1P and related lipids has established 
a role for receptor-mediated lipid signaling events.  Previously an orphan receptor, EDG-
1 was the first putative S1P receptor to be identified (36, 54-56).  To date, seven 
additional EDG receptors have been identified that are differentially activated by S1P, 
SPC and LPA (57-69).   
The variety of sphingolipid signaling molecules that were demonstrated to 
increase [Ca2+]i in enteric glia implies that multiple EDG receptors may be present in the 
ENS.  EDG-1, EDG-3, EDG-5/H218/AGR16, EDG-6, and EDG-8 are responsive to S1P 
(30, 35, 36, 39, 51, 55, 56, 58, 63, 66, 69, 70) and, to a lesser degree, SPC (58, 66, 69, 
70).  EDG-2/Vzg-1, EDG-4, and EDG-7 appear to be selectively sensitive to LPA (57, 59, 
60, 62).  Using RT-PCR, EDG-1, EDG-3 and EDG-5 receptor mRNAs were 
demonstrated in cultured cells from guinea pig myenteric plexus, and expression of each 
of these receptors could be demonstrated immunocytochemically.  The expression of 




responses to S1P and SPC by enteric glia.  Sensitivity of enteric glia to LPA suggests that 
at least one additional receptor (EDG-2, EDG-4, or EDG-7) is likely to be expressed as 




This investigation indicates that S1P is a potent agonist for Ca2+ signaling in 
enteric glia, with dose-dependent effects that were observed at concentrations consistent 
with measurable levels of this compound in serum (71, 72).  S1P responsiveness in 
enteric glia was maintained in Ca2+-free medium and blocked by thapsigargin, implying 
that initial Ca2+ transients are due to release of Ca2+i stores.  Removal of Ca2+ from the 
medium eliminated the sustained "plateau" in Ca2+ transients, consistent with influx of 
Ca2+e following initial Ca2+ release from intracellular stores.  Using rat glioma C6 cells, 
Tas and Koschel (24) showed that S1P evoked Ca2+ release from internal stores and Ca2+ 
influx from the external medium.  
EDG-1, EDG-3, and EDG-5 have all been demonstrated to couple to Gi, but 
EDG-3 and EDG-5 are also capable of interacting with Gq in transfected Sf9 and 
HEK293 cells (73).  If guinea pig EDG-3 couples to Gq, S1P-induced [Ca2+]i transients 
would be anticipated to be insensitive to PTX exposure.  In many cell stypes, Gq proteins 
link GPCRs with PLC.  The current studies convincingly demonstrate that S1P-induced 
calcium signaling is antagonized by the PLC inhibitor U73122, but not by the inactive 




(74, 75).  Based on experiments utilizing 2APB, a selective antagonist of the IP3 receptor, 




While these studies suggest a role for sphingolipid processing in enteric glia, they 
do not exclude Ca2+ signaling by sphingolipid metabolites acting intracellularly.  
Sphingomyelin, a normal constituent of cellular membranes, induced Ca2+ transients in a 
small percentage of enteric glia.  Exposure of cultured glial cells to exogenous 
administration of sphingomyelinase also caused them to undergo Ca2+ signaling.  The 
dose utilized in this investigation (0.1 U/ml) has been previously shown to induce 
mitogenesis of smooth muscle cells by initiating SM metabolism and producing S1P (76).  
Although the initial breakdown product of SM—ceramide—has been demonstrated to 
cause IP3-mediated intracellular Ca2+ release in Xenopus oocytes (77), it had no effect in 
enteric glia.  By utilizing a truncated form of ceramide (C2-CER), which retains 
biological activity yet is less likely to be further metabolized, it appears that the Ca2+ 
transients initiated by proximal components of the sphingomyelin cycle are attributable to 
distal products of catabolism:  sphingosine or S1P. This experiment addresses the 
concern that sphingolipid-induced Ca2+ signaling in enteric glia is due to non-specific 
detergent effects by showing that not all lipids elicit cytoplasmic Ca2+ changes.   
D-erythro-sphingosine caused Ca2+ signaling in enteric glia, but its inactive 
enantiomer (L-erythro-sphingosine) was functionally inert in this experimental model. 




its production by an endoplasmic reticulum-bound sphingosine kinase (26, 40, 76, 78-
82).  Sphingosine kinase stimulation causes phosphorylation of endogenous sphingosine, 
producing S1P, which is believed to function by directly mobilizing intracellular Ca2+ 
(26, 80). While other studies have shown S1P—not sphingosine—serves as a Ca2+i-
mobilizing second messenger, we did not directly demonstrate that sphingosine caused 
Ca2+ signaling only through its intracellular conversion to S1P.  
The establishment of a physiological source of S1P has been elusive.  Two recent 
studies suggest that upon activation with prothrombotic stimuli, platelets release amounts 
of S1P that increase serum levels to around 500 nM (71, 72).  While physiological levels 
of S1P are not known within the gastrointestinal tract, circulating quantities such as those 
described by Yatomi et al. (72) are similar to concentrations used in these studies.  The 
recruitment and activation of platelets during an inflammatory response within the 
gastrointestinal tract could serve as a means of producing local concentrations of S1P that 
would affect enteric glia.  Alternatively, if enteric glia possess the ability to process 
sphingolipids and produce bioactive lipids like S1P, then they may regulate local 
responses to inflammation.   
In conclusion, the data in the current studies show that enteric glial cells are 
selectively responsive to members of the sphingolipid family of molecules and related 
compounds.  The mechanism of S1P signaling is PTX-insensitive and involves 
mobilization of Ca2+i stores through the activation of PLC and subsequent production of 
IP3.  Three S1P receptors (EDG-1, EDG-3 and EDG-5) appear to be expressed in glial 
cells of the ENS.  In addition to responsiveness to peptidergic and purinergic signals, 




functional significance of such a system is currently undefined, these findings represent 
the first evidence of lipid-mediated signaling events in the ENS and suggest that a 
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Figure 2.1.  Summary of sphingomyelin and phosphatidylcholine metabolism.   
The three bioactive lipids sphingosylphosphorylcholine, sphingosine-1-phosphate, and 





































































Figure 2.2.  Ca2+ signaling by bioactive lipids in enteric glia.  Sphingomyelin (SM), 
sphingomyelinase (SMase), D-erythro-sphingosine (D-e-SPH), sphingosine (S1P), 
lysophosphatidic acid (LPA), and sphingosylphosphorylcholine (SPC) activate Ca2+ 
signaling at the indicated doses whereas C2-ceramide (C2-CER) and L-erythro-
sphingosine (L-e-SPH) had no effect.  Δ[Ca2+]i represents the incremental rise in 
intracellular calcium concentration (i.e., the difference between resting and stimulated 
cytosolic [Ca2+]) for all responding cells.  Each compound was superfused for 300 s; 
individual cells were exposed to only one agonist.  For each condition n ranged from 96 
to 184 cells (total number of glia examined was 1187).  Data represent mean±SEM for 
each cell for the Δ[Ca2+]i response and for run averages when determining the percentage 































































































































































































Figure 2.3.  Sphingosine-1-phosphate causes robust Ca2+ signaling in glial cells of the 














































































Figure 2.4.  S1P effects on calcium signaling are specific for glial cells in the ENS.  
Representative tracings following treatment with S1P (1 μM) for 120 s as depicted for  an 
enteric neuron (dashed line) and an enteric glial cell (solid line).  In addition to being 
distinguished from enteric neurons morphologically, enteric glia are not typically 



















































































Figure 2.5.  Concentration-dependent increases in Ca2+ signaling evoked by S1P in 
enteric glia.  S1P at the indicated doses activated Ca2+ signaling that was dose-dependent 
with respect to the percentage of responding cells (A) and the incremental rise in 
intracellular Ca2+ levels ([Ca2+]i), (B).  Each compound was superfused for 120 s; 
individual cells were exposed to only one agonist.  For each condition n ranged from 79 
to 164 cells (total number of glia examined was 801).  Data represent mean±SEM.  *P < 



























































































Figure 2.6.  Desensitization following repetitive S1P exposure.  Repetitive superfusion 
of enteric glia with S1P (1 μM, 60 s) in calcium-containing buffer, separated by 250 s of 
buffer perfusion, evoked decreasing peak [Ca2+]i responses (A).  Subsequent treatment 
with ATP (100 μM) generates a large Ca2+ signal, indicating diminished responsiveness 
to S1P is not attributable to internal Ca2+ store depletion.  This tracing is typical of 116 
glial responses.  B. Compiled data from all generated Ca2+ signals.  Data represent 


















































































Figure 2.7.  S1P signals involve intracellular and extracellular Ca2+.  Removal of 
extracellular Ca2+ from the perfusion buffer had no effect on initial peak responses to S1P 
(1 μM, 120 s) but abolished the sustained plateau found in control conditions.  (n=161 































































Figure 2.8.  Depletion of intracellular Ca2+ (Ca2+i) stores blocks S1P responses.  
Superfusion of thapsigargin (1 μM), an endoplasmic reticulum Ca2+-ATPase inhibitor, 
for 300 s in Ca2+-free buffer causes Ca2+ fluxes in enteric glia by preventing refilling of 
Ca2+i stores.  Subsequent exposure to S1P (1 μM, 120 sec) produced no [Ca2+]i response 
in these cells. n=123 and 90 for control and experimental groups, respectively.  Data 
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Figure 2.9.  Phospholipase C (PLC) activation by S1P.  Enteric glia were treated with 
either the PLC inhibitor U73122 (1 μM) or its inactive analog U73343 (1 μM) before 
exposure to S1P (1 μM).  (n=145, 171, and 170 for control, U73122-treated, and U73343-































































Figure 2.10.  S1P-induced Ca2+i mobilization involves the inositol 1,4,5-trisphosphate 
(IP3) receptor (IP3R).  The cell-permeant IP3R inhibitor 2APB dose-dependently 
reduced S1P responses in enteric glia.  For each condition n ranged from 126 to 195 cells 



































































































































































Figure 2.11.  S1P-responsive G protein-coupled endothelial differentiation gene 
(EDG) receptor mRNAs EDG-1, EDG-3 and- EDG-5 are expressed in the enteric 
nervous system.  RT-PCR products of RNA extracted from 5 d old myenteric plexus 
primary cell cultures corresponding to EDG receptor coding sequences are shown in 
lanes 2-4: EDG-1 (892 bp), EDG-3 (715 bp), and EDG-5 (667 bp).  Lanes 1 and 6 
correspond to molecular size markers.  Lane 5 represents the negative control (RT-PCR 












































Table 2.1.  Percent homology of guinea pig (Cavia porcellus) EDG-1, EDG-3, EDG-5 
sequences to other species.  Information based upon comparison of guinea pig EDG-1 
(876 bp, Genbank accession number AF289990), EDG-3 (689 bp, Genbank accession 
number AF289991), and EDG-5 (607 bp, Genbank accession number AF289992) with 









 DNA Protein 
EDG-1 
 Human  87%   95% 
 Mouse   87%   95% 
 Rat   87%   95% 
EDG-3 
 Human  87%   91% 
 Mouse   87%   90% 
 Rat   88%   92% 
EDG-5 
 Human  88%   91% 
 Mouse   86%   89% 






























Figure 2.12.  Immunocytochemical staining for EDG-1, EDG-3 and EDG-5.  
Myenteric plexus cultures from neonatal guinea pigs were stained for EDG-1 (A), EDG-3 
(C) or EDG-5 (E).  Relevant negative controls are represented in panels B, D and F.  
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[Note:  This chapter has been slightly modified from a published manuscript: Segura, 
B.J., Zhang, W., Cowles, R.A., Xiao, L., Lin, T.R., Logsdon, C., & Mulholland, M.W. 





The enteric nervous system (ENS) plays an integral role in gastrointestinal tract 
function.  Within this intricate network, enteric glia are crucial in the maintenance of 
normal bowel integrity, yet their signaling mechanisms are poorly understood.  We 
recently described a role for the novel lipid signaling molecule sphingosine-1-phosphate 
and its members of the Endothelial Differentiation Gene (EDG) family in the ENS.  With 
the long-term goal of understanding the multiple mechanisms of neurotransmission 




related lysophospholipid: lysophosphatidic acid (LPA).  Here we report that enteric glia, 
and not enteric neurons, selectively respond to LPA—a product of phosphatidylcholine 
metabolism.  LPA causes dose-dependent calcium (Ca2+) signaling in these cells over a 
range from 100 pM to 10 μM.  Our data suggest that LPA functions via an extracellular 
receptor in the ENS.  The elicited calcium transients involve the mobilization of  
intracellular Ca2+ stores followed by the influx of extracellular Ca2+ as LPA signals are 
obliterated following the depletion of intracellular Ca2+ and attenuated by the removal of 
Ca2+e from the perfusion buffer.  This signal transduction cascade appears to at least 
partially involve a G protein of the Gi subtype since pretreatment with pertussis toxin 
reduces the magnitude of LPA transients.   Additionally, repetitive exposure yields 
diminished responsiveness—a hallmark of receptor-mediated desensitization.  Inhibition 
of the inositol 1,4,5-trisphosphate (IP3) receptor abolishes LPA signals, indicating that the 
effects of LPA in enteric glia involve the classic route of receptor-mediated Ca2+ 
signaling rather than coupling to a second messenger other than IP3.  Further supporting a 
receptor-mediated event, RT-PCR analysis demonstrates the presence of two LPA-
coupled EDG receptor mRNAs (EDG-2 and EDG-7) in myenteric plexus primary 
cultures.  EDG-2 expression in glial cells of the ENS was confirmed 
immunocytochemically.  Taken together with our previous data on S1P signaling in 
enteric glia, we conclude that multiple lipid-activated signaling mechanisms exist in these 
cells.  We propose that in addition to established traditional peptidergic and purinergic 






A family of signaling molecules and growth factors, collectively known as 
“bioactive lipids”, includes sphingosine-1-phosphate (S1P) and lysophosphatidic acid 
(LPA).  Both are products of membrane lipid catabolism.  S1P is enzymatically generated 
from sphingomyelin whereas LPA is derived from phosphatidylcholine [see Chapter 2, 
Figure 2.1].  Each lysophospholipid has been implicated in a diverse array of cellular 
events including cell growth and differentiation, cytoskeletal changes and cell migration, 
and calcium (Ca2+) signaling (1-5).  The Ca2+ ion is a critical second messenger which 
serves to transduce extracellular signals into biological responses.  In neural systems, 
cytosolic levels of Ca2+ are an integral factor in gene expression, apoptosis, intercellular 
communication, synaptic neurotransmission, and long-term potentiation—events in 
which glia participate (6). 
LPA and S1P are distinctive in that, although lipids, they act as extracellular 
signaling molecules in a receptor-mediated fashion (7).  A family of G protein-coupled 
receptors with affinity for S1P (endothelial differentiation gene receptors:  EDG-1, EDG-
3, EDG-5, EDG-6, and EDG-8) and LPA (EDG-2, EDG-4, and EDG-7) has been 
described (8-10).  Although the evidence in support of S1P and LPA functioning via 
extracellular receptors is convincing, the mechanisms responsible for Ca2+ mobilization 
are not completely defined.  A role for these bioactive lipids in the enteric nervous system 
has not been recognized. 
We hypothesized that LPA could serve as a signaling molecule within the 




EDG-4, or EDG-7.  The current studies of the mechanisms by which LPA affects 
intracellular Ca2+ concentration ([Ca2+]i)  in enteric glia demonstrate that:  1) LPA causes 
dose-dependent Ca2+ signaling; 2) LPA transients involve intracellular and extracellular 
Ca2+;  3) LPA-induced Ca2+ responses desensitize with repetitive exposure; 4) LPA 
effects are attenuated by pertussis toxin exposure; 5) LPA mobilizes thapsigargin- and 
inositol-1,4,5-trisphosphate-sensitive intracellular Ca2+ stores; and 6) myenteric plexus 
cultures express EDG-2, and EDG-7 receptor mRNA, with EDG-2 demonstrated 
immunocytochemically in enteric glia.   
Experimental Methods 
 
Materials and Reagents 
 
 
Lysophosphatidic acid (LPA), adenosine triphosphate (ATP), collagenase type V, 
thapsigargin, U73122, U73343, trypsin-EDTA, soybean trypsin inhibitor (type I-S), 
penicillin-streptomycin solution, N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid 
(HEPES), and saponin were from Sigma Chemical (St. Louis, MO).  Pertussis toxin 
(PTX) was from Calbiochem (San Diego, CA).  Hanks’ balanced salt solution (HBSS), 
medium 199, and L-glutamine were from GIBCO BRL (Grand Island, NY).  Rat tail 
collagen was from Boehringer Mannheim (Mannheim, Germany).  New Serum I (NSI) 
was from Collaborative Research (Bedford, MA).  2-aminoethoxydiphenyl borate (2-
APB) was from Tocris (Ballwin, MO).  Fura-2-AM, fluorescein conjugated streptavidin 




7481) were from Molecular Probes, Inc. (Eugene, OR).   TRIzol reagent, DNAse I, 
SuperScript II RNase H- Reverse Transcriptase (RT), and RT buffer were from Life 
Technologies, Inc. (Grand Island, NY).  Deoxynucleotides (dNTP mix) and oligo d(T) 
primers were from Roche Molecular Biochemicals (Indianapolis, IN).  RNase inhibitor 
was from Promega (Madison, WI).  Advantage cDNA polymerase mix and PCR reaction 
buffer were from Clontech Laboratories, Inc. (Palo Alto, CA). EDG-2 C-terminus rabbit 
polyclonal Ab (C174P), EDG-2 blocking peptide (X1269B), and EDG-4 N-termimus 
mouse monoclonal Ab (C180M) are from Exalpha Biologicals, Inc. (Boston, MA). One-
day-old male Duncan-Hartley guinea pigs were obtained from Simonsen Labs (Gilroy, 
CA).   
 
Myenteric Plexus Isolation 
 
Dispersed primary cultures of guinea pig myenteric plexus were prepared on 
collagen-coated coverslips and used for experiments within 10 days post-plating using a 
protocol refined in our laboratory (11).  One- to three-day-old Duncan Hartley guinea 
pigs were sacrificed and their taenia coli were removed using sharp dissection with tissue 
forceps and Castro-Viejo scissors then placed in Hanks Balanced Salt Solution 
supplemented with 0.1% Type IV collagenase for 16-24 h at 4oC.  After a 30-60 minute 
incubation at 37oC, the muscle layers of the taenia coli were separated from the myenteric 
plexus with the use of fine tissue forceps and a dissecting microscope.  The myenteric 
plexus was trypsinized for 30 min at 37oC using 0.1% trypsin-EDTA solution, triturated 
with siliconized flamed Pasteur pipettes of decreasing diameter, and plated on 




using sterile technique.  Cultures were exposed to complete medium 199 plus 5% NSI 
and 0.01% trypsin inhibitor.  Penicillin-streptomycin solution was added for the first 48 h 
at a 2% concentration.  Antimitotic agents were not added.  Medium was changed every 
24-36 hours.  The cultures were incubated at 37oC with 5% CO2.  All animals were used 
in accordance with established guidelines and protocols approved by the University 
Committee on the Use and Care of Animals at the University of Michigan Medical 




All experiments were performed in standardized solutions except when noted.  
Standard control buffer was a modified Krebs-Ringer solution at pH 7.40 containing (in 
mM) 118 NaCl, 4.7 KCl, 1.8 CaCl2, 10 HEPES, 15 NaHCO3, 11 glucose, 0.9 NaH2PO4, 
and 0.8 MgSO4.  In Ca2+-free control buffer, the CaCl2 was omitted and 0.5 mM EGTA 
was added.   
 
Loading and Cell Preparation for Imaging 
 
For loading purposes, fura 2-AM was added to achieve a final concentration of  2 
μM for 45 min to cultured myenteric plexus and incubated at 370C in serum-containing 
growth media described above that was changed no less than 24 hours prior to avoid 
acute effects of new serum supplementation.  Loaded coverslips were washed and then 




(approximate volume 0.5 ml).  The superfusion rate of the control buffer and 




A Zeiss Axiovert inverted microscope and an Attofluor imaging system 
(Rockville, MD) were used to determine single-cell intracellular Ca2+ concentration 
([Ca2+]i).  [Ca2+]i was calculated from the ratios of the fluorescence intensities of fura-2 at 
334 and 380 nm, monitored by an intensified charge-couple device camera, and 
subsequently digitized.  Calibration of the system was performed with the two-point 
standardized equation, using fura-2-free acid: 
 
[Ca2+]i = Kd [(R-Rlow)/(Rhigh - R)]b 
 
where Kd is the dissociation constant of the Ca2+-fura 2 complex (225), R is F334/F380, i.e., 
the fluorescence at 334 nm excitation divided by the fluorescence at 380 nm excitation, 
Rlow is the ratio at zero Ca2+ (1 mM EGTA), Rhigh is the ratio at high Ca2+ (1 mM CaCl2), 
and b is F380 (zero Ca2+)/F380 (saturating Ca2+).  Frames were not averaged to obtain 
images.  The system was used to obtain whole field images.  Boxes were placed on all 
cells of interest for simultaneous measurement of intracellular Ca2+ concentration 





RNA Extraction and Reverse Transcription (RT) 
 
Total cellular RNA was isolated from 5 day-old myenteric plexus primary cell 
cultures using TRIzol reagent according to manufacturer’s directions.  Single strand 
cDNA synthesis was performed as follows: 20 µl of reverse transcription mixture 
contained 1 µg of DNase I pre-treated total RNA, 0.5 µg of oligo d(T) primer, 4 µl of 5 x 
RT buffer, 10 mM dithiothreitol, 0.5 mM deoxynucleotides, 40 units of RNase inhibitor, 
and 200 units of reverse transcriptase (SuperScript II RT).  The RT reaction was carried 
out at 42oC for 50 min followed by heat inactivation at 70oC for 15 min. 
 
Polymerase Chain Reaction (PCR) 
 
Fifty μL of PCR reaction mixture contained 1 µl of RT products, 1X cDNA PCR 
reaction buffer, 400 nM of each primer, 200 µM of dNTP mix, and 1X Advantage cDNA 
polymerase mix.  The PCR was carried out using a Perkin-Elmer Thermal Cycler 
(Norwalk, CT).  Samples were denatured initially at 94oC for 1 min and the PCR was 
performed as follows: 38 cycles of 35 sec at 94oC, 30 sec at 57oC and 1 min 45 sec at 
72oC for EDG-2; 42 cycles of 30 sec at 94oC, 30 sec at 65 oC and 1 min 30 sec at 72oC for 
EDG-4; 38 cycles of 35 sec at 94oC, 2 min at 68oC, and 7 min at 72oC for EDG-7, 
following by the final extension at 72 oC for 7 min. 
PCR primers used for guinea pig mRNA detection were deduced from human, 
mouse and rat published sequences. The nucleotide sequences of sense and antisense 




CTA CAA CGA G (sense) and GCA GCA GAG AAG GCG GCG GAA GGT G 
(antisense) (927 bp); EDG4, CAT GGG CCA GTG CTA CTA CAA CGA G (sense) and 
CGG AAG GTG CGG CGC ATC TCA G (antisense) (912 bp); EDG-7, ACT TGC TGG 
TTA TCG CCG TGG AGA GG (sense) and CTG CTG AGG ACT GTG GAG GGG 
ATG C (antisense) (634 bp).  For negative controls, PCR reactions were performed for 
each of the primer pairs in the absence of transcript as others have reported.  
 
Sequencing and Data Analysis 
 
PCR products were electrophoretically analyzed on 1.5% agarose gel containing 
ethidium bromide.  DNA bands were excised from the gel and purified as follows: gel 
slices were crushed in the tube and sample DNA was extracted twice with buffered 
phenol and once with phenol:chloroform:isoamyl (25:24:1) followed by ethanol 
precipitation with 0.1  volume of 3M sodium acetate (pH 5.2) and 2.5 volume of 100% 
ethanol and washing with 70% ethanol.  The purified DNA fragments were directly 
sequenced by the DNA sequencing core at the University of Michigan using Applied 
Biosystems DNA sequencers. The nucleotide sequences of EDG-2 and EDG-7 have been 




Cultured guinea pig myenteric plexus cells were used on day 5 or day 6.  Cells 




steps were performed at 4oC unless otherwise noted.  Following rinsing in PBS, the cells 
were incubated with blocking/permeabilization buffer (10% normal goat serum, 2% BSA 
and 0.1% saponin in PBS) for 20 min at room temperature.  After washing with PBS, the 
cells were incubated with primary antibody solution overnight at 4oC.  Mouse 
monoclonal antibody against EDG4 was diluted at 1:50 in PBS with 1.5% goat serum.  
Rabbit polyclonal antibody against EDG2 was diluted at 1:100 in PBS with 1.5% goat 
serum.   As a negative control, rabbit polyclonal antibodies were pre-incubated with 
specific blocking peptides for 20 min at 37O C; the sample without primary antibody was 
used for negative control for mouse monoclonal antibody samples.  After thoroughly a 
wash with PBS, the samples were incubated for 45 min with biotinylated goat anti-mouse 
or anti-rabbit antibody (1:200 diluted in PBS with 1.5% goat serum), illuminated by 
reaction with fluorescein conjugated streptavidin, stained with DAPI cytological nuclear 
conterstain kit and mounted with prolong antifade kit following company instructions.  
Samples were examined using a Nikon microscope with epifluorescence capabilities and 
images were recorded using a Spot camera then processed in Adobe photoshop. 
 
Data Presentation and Calculation 
 
Results are expressed as mean ± SEM.  Data were analyzed using ANOVA.  
Significance was accepted as P < 0.05 (95% confidence interval).   
Dissection techniques, tissue preparation, media, and reagent vendors remained 
constant throughout the study.  In this study, n equals the number of glial cells examined.  




conditions were examined on glial cells derived from cell preparations performed on at 
least two different days.   
Results have been calculated only from those responding glia having basal [Ca2+]i 
levels < 100 nM, a criteria met by > 95% of glial cells.  Cells were considered to be 
responsive if peak [Ca2+]i was at least 50 nM higher than the baseline value.  Glia with a 
high [Ca2+]i before any addition of agonist were considered damaged or leaky and were 
excluded from the study.  Only one microscope field was examined per coverslip.  Peak 
[Ca2+]i was measured as the highest [Ca2+]i achieved during agonist exposure.  Δ[Ca2+]i 
represents the difference between peak and basal [Ca2+]i. 
At the time of the experiments, two criteria were used to determine whether cells 
of interest were glial cells, as opposed to neurons.  1) Morphology.  Myenteric neurons 2-
7 days post-plating are compact and phase-bright, with few or no processes.  Enteric glia 
have a larger, dense nucleus with wide surrounding cytoplasm.  2) KCl depolarization.  
At the end of each experiment, the coverslip was superfused with 55 mM KCl.  Enteric 
glia typically do not exhibit increments in [Ca2+]i on exposure to 55 mM KCl.  
 
Experimental Results  
 
Lysophosphatidic Acid (LPA) Dose-Dependently Causes Ca2+ Signaling in Enteric 
Glia.   
 
Perfusion of glial cells with LPA (1 μM) for 120s caused Ca2+ mobilization in 




increments in the percentage of cells responding [Figure 3.1b] and in the elicited [Ca2+]i 
increments [Figure 3.1c] over the range of 100 pM to 10 μM, with the EC50 of 86 nM.  
For remaining experiments, 1 μM LPA was chosen as a suitable working dose.   
 
LPA-Mediated Ca2+ Signaling Desensitizes with Repetitive Exposure.  
 
Repetitive exposure to LPA produced progressive decrements in peak [Ca2+]i in 
enteric glia [Figure 3.2a].  An approximately 25% decrease in peak [Ca2+]i responses was 
observed between first and second LPA exposures, and another decrement of 30% 
between the second and third exposures [Figure 3.2B].  92% of cells responded to LPA 
and 13% completely desensitized (n=176).  To demonstrate that the effect was not due to 
depletion of intracellular Ca2+ stores, cells were subsequently perfused with ATP (100 
μM) at the end of each experiment and typical  increments in [Ca2+]i were achieved.  The 
ATP-induced increment in [Ca2+]i after repetitive exposure to LPA was comparable to the 
responsiveness to the initial ATP perfusion (455±38, n=301 vs. 469±57 nM, n=117, 
P>0.05) 
 
LPA Responses are Pertussis Toxin (PTX)-Sensitive.  
 
To investigate the involvement of a PTX-sensitive G protein, enteric glia were 
preincubated with PTX at 100 ng/ml for 24 h, a concentration and preincubation time 
found to be inhibitory in other studies.  The percentage of cells responding to LPA was 




treated cells, respectively [Figure 3.3a].  Peak [Ca2+]i generated by LPA in glia pre-
exposed to PTX was 95+20 nM (n=138), relative to the peak [Ca2+]i evoked in control 
glia of 168+17 nM (n=172) [Figure 3.3b].   
 
LPA Mobilizes Intracellular Ca2+ Stores and Activates Extracellular Ca2+ Influx.  
 
To evaluate the role of intracellular Ca2+ (Ca2+i) stores in LPA-generated calcium 
signaling, responsiveness of enteric glia to LPA was investigated using Ca2+-free medium 
supplemented with 1 mM EGTA.  Exposure to LPA in a nominally Ca2+-free medium 
had a minimal effect on the percentage of cells responding or on peak [Ca2+]i.  The 
morphology of the observed Ca2+ transients, however, was distinctly different [Figure 
3.4a].  The absence of extracellular Ca2+ (Ca2+e) abolished the sustained plateau in 
intracellular [Ca2+], indicating that an influx of Ca2+e occurs following initial Ca2+i 
mobilization.  Thapsigargin, an inhibitor of the endoplasmic reticulum Ca2+-ATPase, 
depletes Ca2+i stores without generating IP3.  During superfusion with thapsigargin (1 
μM) in a Ca2+-free medium, all cells (n=113) responded with increases in [Ca2+]i, 
followed by return of [Ca2+]i to baseline; at this point, Ca2+i stores were presumed to be 
depleted.  Subsequent exposure to LPA produced Ca2+ transients in none of the glial cells 
examined [Figure 3.4b].  At the end of each experiment, perfusion with Ca2+-containing 





LPA-Induced Ca2+i Mobilization Involves the Inositol 1,4,5-Trisphosphate (IP3) 
Receptor (IP3R). 
 
The role of IP3-sensitive intracellular Ca2+ stores in LPA signaling was 
investigated using the membrane-permeable IP3R antagonist 2APB.  2APB has been 
utilized in a variety of cell types to reversibly modulate IP3R activity independent of IP3 
production and binding, voltage-gated calcium channels, or ryanodine-sensitive calcium 
stores.  In this investigation, 2APB had no effect on basal cytosolic [Ca2+]i.  Following 
pretreatment with 2APB (200 μM) for 5 min, only 21% of glia (n=135) responded to 
LPA exposure vs. 89% for controls (n=141) [Figure 3.5].    
 
EDG-2 And EDG-7 mRNAs are Expressed in the ENS.   
 
To further assess the participation of LPA-responsive G protein-coupled receptors 
of the endothelial differentiation gene family, RT-PCR analysis was performed using 
primers generated from known human and rodent coding sequences.  Five day old mixed 
primary cultures from guinea pig myenteric plexus express mRNA corresponding to 
EDG-2 and EDG-7; mRNA corresponding to EDG-4 was not detected [Figure 3.6].  
Sequence analysis indicated that these mRNAs in the guinea pig have a high degree of 
homology with known nucleotide and amino sequences from human, rat, and mouse.   
In prior studies, we have demonstrated that cells with distinct glial morphology 
stain positively immunocytochemically for glial fibrillary acidic protein and S-100, while 




(neurons).  The current study revealed that enteric glial cells stain strongly for EDG-2 but 
only display trace positivity for EDG-4 [Figure 3.7]. Enteric neurons stained negative for 




The current study demonstrates that enteroglial cells from the guinea pig 
myenteric plexus respond to lysophosphatidic acid via EDG-2 receptors.  The findings 
that support this conclusion are five-fold:  1) LPA produces increments in [Ca2+]i which 
are dose-dependent and desensitize with repetitive exposure; 2) responsiveness to LPA is 
sensitive to pertussis toxin exposure; 3) LPA mobilizes intracellular Ca2+ stores that are 
released via a mechanism involving IP3 receptor activation; 5) RT-PCR analysis of 
guinea pig myenteric plexus reveals production of EDG-2 and EDG-7 mRNA, with 
EDG-2 receptors detected immunocytochemically in enteroglial cells. 
Enteric glia outnumber enteric neurons by 2:1 and share morphological 
similarities to CNS astrocytes; they have irregular shapes, express glial fibrillary acidic 
protein and do not synthesis a basal lamina (12).  Recent reports have demonstrated that 
astrocytes are active participants in CNS synaptic transmission, in addition to serving 
supportive and nutritive functions.  Enteric glial cells may also exhibit functional 
properties similar to CNS astrocytes.  Enteric glia, like astrocytes, undergo Ca2+ signaling 
in response to purinergic compounds and to a variety of neuropeptides (11, 13, 14).  The 
finding that lysophosphatidic acid is a potent agonist for Ca2+ signaling in enteric glial 




activity within the myenteric plexus.  The ability of LPA, a bioactive lipid derived from 
phosphatidylcholine, to activate myenteric glia has not been previously reported. 
 
Lysophosphatidic Acid and EDG Receptors 
 
The recent characterization of a family of G-protein-coupled receptors with 
affinity to bioactive lipids has established a role for receptor-mediated lipid signaling 
mechanisms.  The Endothelial Differentiation Gene-1 (EDG-1) receptor was the first 
member of this group recognized, with sphingosine-1-phosphate (S1P) as its ligand (8, 
15).  Currently, seven additional EDG receptors have been reported.  The varying EDG 
receptors are differentially activated by S1P, sphingosylphosphorylcholine (SPC) and 
LPA.  EDG-1, EDG-3, EDG-5, EDG-6 and EDG-8 are selective for S1P, and, to a lesser 
degree, to SPC; EDG-2, EDG-4 and EDG-7 are sensitive to LPA (8-10).  Using RT-PCR, 
EDG-2 and EDG-7 mRNA was detected in the mixed cellular culture of guinea pig 
myenteric plexus, while EDG-4 was not identified.  Myenteric cells with the 
morphological and immunostaining characteristics of enteroglia were demonstrated to 
express EDG-2 immunopositivity, consistent with responsiveness to extracellularly 
applied LPA. Although enteric neurons are also present in these cultures, two 
observations indicate that enteric neurons do not contribute to glial Ca2+ response to 
LPA: (1) enteric neurons did not respond to LPA with Ca2+ transients; (2) 








A common feature of LPA signaling in many cell types is the ability of this 
compound to increase intracellular calcium levels.  In Tag-Jurkat T cells transiently 
transfected with human EDG-2 cDNA, extracellular LPA stimulated an initial increase in 
[Ca2+]i followed by a more prolonged influx of extracellular Ca2+ (16).  A similar general 
mechanism was demonstrated in enteric glial cells.  In the current study, LPA 
responsiveness in enteric glia was maintained in Ca2+-free media and was blocked by 
thapsigargin, implying that initial Ca2+ transients are due to release of Ca2+i stores.  
Removal of Ca2+ from the medium eliminated the sustained plateau in Ca2+ transients, 
consistent with influx of Ca2+e following initial Ca2+ release from intracellular stores. 
EDG receptors responsive to LPA have been shown to couple to at least three G-
proteins: Gq, Gi, and G12/13 (17).  When recombinant human EDG-2 was stably 
transfected into rat HTC4 hepatoma cells, LPA-induced mobilization was almost 
completely blocked by pertussis toxin, indicating mediation via Gi (16).  Similarly, in 
MG63 human osteosarcoma cells, LPA-stimulated activation of Erk1/2 was Gi-dependent 
(18).  In contrast, Ishii and colleagues have reported that mouse EDG-2 (LPA1) can 
couple to multiple G-proteins to induce LPA-dependent inositol phosphate production, 
MAP kinase activation or arachidonic acid release (18).  In the current study, 
pretreatment of enteric glial cells with pertussis toxin reduced LPA-stimulated [Ca2+]i 
transients by nearly 50%, consistent with involvement of Gi.  The action of 2APB, an 
inhibitor of the IP3 receptor, strongly suggests the LPA-induced Ca2+ mobilization is 




upon repetitive exposure to LPA is consistent with the event mediated by G-protein-
coupled receptors. 
 
A Potential Role for LPA in the ENS 
 
 The physiological source of LPA within the enteric nervous system is unknown.  
LPA is produced as a result of cleavage of membrane-associated phospholipids by 
phospholipase A2.  Activated platelets are an abundant source of extracellular LPA, and 
serum concentrations in the micromolar range, substantially higher than those used in the 
current study, have been reported (19).  The recruitment and activation of platelets to an 
area of vascular injury could potentially expose myenteric plexus cells to LPA.  
Alternatively, if enteric glial cells, or other cellular componenets of the enteric nervous 
system, possess the ability to release bioactive lipids, these cells might also locally 
regulate inflammatory responses. 
In summary, the current study demonstrates that enteric glial cells respond to LPA 
and that such responses may be mediated by EDG-2 receptors.  The resulting Ca2+ signal 
is pertussis toxin-sensitive and involves mobilization of intracellular Ca2+ stores through 
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Figure 3.1. Concentration-dependent increases in Ca2+ signaling evoked by LPA in 
enteric glia.  Lysophosphatidic Acid (LPA) (1μM) activates Ca2+ signaling in enteroglial 
cells (A).  Myenteric neurons were unresponsive to LPA.  LPA at the indicated doses 
activated Ca2+ signaling that was dose-dependent with respect to the percentage of 
responding cells (B) and the incremental rise in intracellular Ca2+ levels ([Ca2+]i), (C).  
LPA was superfused for 120 s; individual cells were only exposed to LPA once.  For 
each condition n ranged from 95 to 182 cells (total number of glia examined was 719).  



















               

















              


















































Figure 3.2. Desensitization following repetitive LPA exposure.  Repetitive superfusion 
of enteric glia with LPA (1μM), 60s) in calcium-containing buffer, separated by a 
washout period of 200 s with buffer perfusion, evoked decreasing peak [Ca2+]i responses 
(A).  Subsequent treatment with ATP (100μM) generates a typically large Ca2+ signal, 
indicating diminished responsiveness to LPA is not attributable to internal Ca2+ store 
depletion.  This tracing is typical of 124 glial responses.  B. Compiled data from all 
generated Ca2+ signals.  Data represent mean±SEM.  *P < 0.05 versus initial response 












































































Figure 3.3. LPA signaling is PTX-sensitive.  Cultured enteric glial cells were incubated 
with 100 ng/ml PTX for 24 h and then exposed to 1 μM LPA. Percentage of cells 
responding (A) and Δ[Ca2+]i (B) were measured.  Data represent mean±SEM.  *P < 0.05 












































































Figure 3.4. LPA signals involve intracellular and extracellular Ca2+.  A. Removal of 
extracellular Ca2+ from the perfusion buffer had no effect on initial peak responses to 
LPA (1μM, 120) but abolished the sustained plateau found in control conditions. At the 
end of experiment, perfusion with 100μM ATP induced [Ca2+]i response, demonstrating 
cellular viability. (n=158). B. Depletion of intracellular Ca2+ stores by thapsigargin 
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Figure 3.5. LPA-induced Ca2+i mobilization involves the inositol 1,4,5-trisphosphate 
receptor.  LPA was superfused for 120 s following pre-treatment with 2-
aminoethoxydiphenylborate (2APB), an IP3R antagonist (n=141). Subsequent exposure to 








































































Figure 3.6. LPA-responsive G protein-coupled endothelial differentiation gene 
(EDG) receptor mRNAs EDG-2 and EDG-7 are expressed in the enteric nervous 
system.  RT-PCR products of RNA extracted from 5 d old myenteric plexus primary cell 
cultures corresponding to EDG receptor coding sequences are shown in lanes 2 and 3:  
EDG-2 (925 bp) and EDG-7 (634 bp).  Lanes 1 and 5 correspond to molecular size 
markers.  Lane 4 represents the negative control (RT-PCR performed without the 





























































Figure 3.7. Immunocytochemical  staining for EDG-2 and EDG-4.  Myenteric plexus 
cultures from neonatal guinea pigs were stained for EDG-2 (A) or EDG-4 (B).  Relevant 
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SPHINGOSINE-1-PHOSPHATE AND RELATED BIOACTIVE LIPIDS INDUCE 
EARLY RESPONSE GENE EXPRESSION IN C6 GLIOMA CELLS 
 
[Note:  This chapter has been slightly modified from a submitted manuscript: Segura, 
B.J., Zhang, W., Xiao, L., Logsdon, C., & Mulholland, M.W. 2005. Sphingosine-1-
phosphate induces early response gene expression in C6 glioma cells.  Brain Res. Mol. 





Sphingosine-1-phosphate (S1P), a product of sphingomyelin catabolism, causes 
receptor-mediated calcium signaling in a variety of glial subtypes.  Activation of early 
response gene expression by S1P and related lipids was examined in C6 glioma cells.  
S1P caused dose-dependent increases in c-fos mRNA at doses ranging from 1 μM 
(194±13% of control) to 100 μM (446±41%).  Expression of c-fos was evident at 15 min 
(301±45%), greatest at 30 min (303±24%), and subsided within 1h (131±13%).  Similar 
effects were found with the early response genes jun-B. Related lipids also induced c-fos 




188±41%), and sphingosylphosphorylcholine (SPC, 100 μM—420±44%) elicited 
significant rises in c-fos levels following 30 min of exposure.  Pretreatment with PTX 
(100 ng/ml X 24h), reduced c-fos activation by S1P (100μM—187±6% vs. 411±27%) 
and LPA (100 μM—90±34% vs. 188±41%), but not by SPC (100μM—390±47% vs. 
420±44%).  RT-PCR analysis and sequencing demonstrated the presence of previously 







Sphingolipid metabolites have received increasing attention as a new class of 
signaling molecules.  Sphingosine, sphingosine-1-phosphate (S1P), and lysophosphatidic 
acid (LPA) are members of this group of lipid signaling molecules.  S1P is generated 
through sphingomyelin catabolism and has been implicated in an array of cellular events 
ranging from cellular proliferation, to shape change and cellular motility (1-3). S1P is 
functionally distinctive, serving either an extracellular or an intracellular role, depending 
upon cell type (1-4).  The actions of S1P as an extracellular signaling molecule have been 
confirmed by the identification of a family of G-protein coupled receptors with affinity 
for S1P (Endothelial Differentiation Gene [EDG] receptors) (5-7).  Although a number of 
recent reports support a role for S1P functioning via an extracellular receptor, the 
intracellular signaling pathways subsequently activated remain incompletely defined.  
The current study was designed to investigate whether exposure of C6 glioma 
cells to S1P stimulates the expression of the immediate early response genes c-fos and 
jun-B.  The c-fos proto-oncogene was among the first immediate early response genes 
identified and is well characterized.  The product of the c-fos gene combines with the 
products of the jun family of proto-oncogenes to form heterodimeric transcription factor 
complexes.  Fos/Jun heterodimers bind with high affinity to genes that contain the AP-1 
DNA consensus sequence.  When a c-fos/c-jun heterodimer binds to an AP-1 site it 
activates transcription, whereas c-fos/jun-B heterodimer binding at an AP-1 site represses 
transcription of the involved gene. 
The current studies demonstrate that: 1) S1P mediates time- and dose-dependent 




(PTX), a Gi antagonist, and by U73122, an inhibitor of phospholipase C; 3) the related 
sphingolipids sphingosylphosphorylcholine and LPA also stimulate c-fos expression and 
display differential sensitivity to PTX; and 4) EDG-2 and EDG-4 receptor mRNA is 




Materials and Reagents 
 Sphingosine-1-phosphate (S1P), D-erythro-sphingosine (DSPH), 
lysophosphatidic acid (LPA), sphingosylphosphorylcholine (SPC), sphingomyelin (SM), 
C2-ceramide (C2-CER), sphingomyelinase (SMase), collagenase type V, soybean trypsin 
inhibitor (type I-S), penicillin-streptomycin solution, and N-2-hydroxyethylpiperazine-
N’-2-ethanesulfonic acid (HEPES) were from Sigma Chemical (St. Louis, MO). U73122, 
and U73343 were obtained from Research Biochemicals International (Natick, MA). 
(Beverly, MA). Dulbecco’s modified Eagle’s medium (DMEM), phosphate buffered 
saline (PBS), fetal calf serum, L-glutamate, and Trizol total RNA isolation kit were 
purchased from GIBCO Life Technologies, Inc (Rockville, MD). Radiolabeled (α-
32P)dCTP (3,000Ci/mmol), Rediprime DNA labelling kit were purchased from 
Amersham (Arlington, IL). Maximum Nytran nylon membranes and PDFV membranes 
were obtained from Schleicher and Schuell (Keene, NH). QuikHybe hybridization buffer 
was from Stratagene (La Jolla, CA). Qiaex II agarose gel extraction kits and Plasmid 
Maxi-Pre kits were obtained from Qiagen (Santa Clarita, CA). Midi select G-50 




gels for SDS-polyacrylamide gel electrophoresis (PAGE) were obtained from Bio-RAD 




cDNA probes used for these studies included c-fos, c-jun,  jun-B and jun-D cDNA 
purchased from ATCC (American Type Culture Collection) and a cDNA for chicken 
gluceraldehyde-3- phosphate dehydrogenase (GAPDH) (Dugaiczyk et al, 1983). Plasmids 
containing probes were isolated from bacterial cultures using Qiagen Maxi-Pre isolation 
kits. A 920 bp Pst I fragment of c-fos and a 1 kb Pst I fragment of cGAPDH were cut 
with restriction enzymes and isolated from agarose gels using Qiaex II gel isolation kits.  




C6 cells, a rat glioma cell line, were obtained from ATCC and cultured in DMEM 
media supplemented with 5% fetal calf serum, 100 IU/ml penicillin, and 100mg/ml 
streptomycin. Cells were used between passage 40 and 60. For experiments, cells were 
seeded at a 3X106 cells/10 cm dish and grown in 5% CO2 humidified condition. Cells at 
80% confluence were depleted of serum overnight and then treated with sphingolipid 
compounds. When used, inhibitors were present during a preincubation period of 30 





Northern Blot Analysis 
Cells were harvested and total RNA isolated using Trizol reagent. Equal amounts 
of RNA (25μg/lane) were denatured and electrophoresed on 1.2% agarose-6% 
formaldehyde gels, transferred to nylon membranes, and immobilized by UV cross-
linking (Stratalinker, Stratagene). cDNA probes were labeled with 32P dCTP using a 
random hexanucleotide priming kit followed by purification using a G50 sephadex spin 
column. Membranes were pre-hybridized for 20-30 minutes at 68 °C in QuikHybe 
suspension supplemented with 100μg/ml sonicated salmon sperm DNA. Hybridization 
with the 32P-labeled probes was carried out at 68 °C for 1 hour. Membranes were washed 
in 2X SSC/0.1%SDS at room temperature, followed by 0.1XSSC/0.1%SDS at 60 °C, and 
exposed to X-ray film (Kodak X-Omat AR, Rochester,NY) with intensifying screens at  -
70°C. GAPDH marker was used to normalize signals. All experiments were repeated at 
least three times. 
 
RNA extraction and Reverse Transcription (RT) 
 
Total cellular RNA was isolated from C6 cell cultures using TRIzol reagent (Life 
Technologies, Inc., Grand Island, NY) according to manufacturer’s directions.  Single 
strand cDNA synthesis was performed as follows: 20 µl of reverse transcription mixture 
contained 1 µg of DNase I pre-treated total RNA, 0.5 µg of oligo d(T) primer (Roche 
Molecular Biochemicals, Indianapolis, IN), 4 µl of 5 x RT buffer, 10 mM dithiothreitol, 




and 200 units of reverse transcriptase (SuperScript II RT, Life Technologies).  The RT 
reaction was carried out at 42oC for 50 min followed by heat inactivation at 70oC for 15 
min. 
 
Polymerase Chain Reaction (PCR) 
 
50 μL of PCR reaction mixture contained 1 µl of RT products, 1X cDNA PCR 
reaction buffer (Clontech Laboratories, Inc., Palo Alto, CA), 400 nM of each primer, 200 
µM of dNTP mix, and 1X Advantage cDNA polymerase mix.  PCR was carried out using 
a PTC-200 DNA engine (MJ Research, Inc., Waltam, MA).  Samples were denatured 
initially at 94oC for 1 min and the PCR was performed as follows: 32 cycles of 30 sec at 
94oC, 30 sec at 65oC and 1 min at 72oC for EDG-2; 42 cycles of 30 sec at 94oC, 30 sec at 
65oC and 1 min 30 sec at 72oC for EDG-4, followed by the final extension at 72oC for 7 
min. 
PCR primers used for rat C6 cell mRNA detection were deduced from human, 
mouse and rat published sequences. The nucleotide sequences of sense and antisense 
primers with the expected product size are as follows: EDG-2, AGT ATC TAG CCA 
CAG AAT GGA ACA CT (sense) and AAC ACA CAT CGA GTA GCA AGA C 
(antisense) (735 bp product); EDG-4, CAT GGG CCA GTG CTA CTA CAA CGA G 
(sense) and CGG AAG GTG CGG CGC ATC TCA G (antisense) (912 bp product).   For 
negative controls, PCR reactions were performed for each of the primer pairs in the 





Sequencing and Data Analysis 
 
PCR products were electrophoretically analyzed on 1.2% agarose gel containing 
ethidium bromide.  DNA bands were excised from the gel and purified as follows: gel 
slices were crushed in the tube and sample DNA was extracted twice with buffered 
phenol and once with phenol:chloroform:isoamyl (25:24:1) followed by ethanol 
precipitation with 0.1  volume of 3M sodium acetate (pH 5.2) and 2.5 volume of 100% 
ethanol and washing with 70% ethanol.  The purified DNA fragments were directly 
sequenced by the DNA sequencing core at the University of Michigan using Applied 
Biosystems DNA sequencers.  
 
Data Presentation 
Results are expressed as mean + SEM.  Data were analyzed by analysis of 




S1P dose-dependently increased c-fos mRNA expression in C6 cells over a range 
of 10 nM to 100 μM [Figure 1].  These concentrations were selected based on 
preliminary studies using fura-2-based increments in intracellular Ca2+ as a marker of 
cellular responsiveness. C6 cells reversibly responded to S1P (10 nM to 100 μM) with 
increases in intracellular calcium concentration. Subsequent exposure to ATP (100 μM) 




viability of C6 cells exposed to S1P. To evaluate the time course of c-fos transcription, 
C6 cells were treated with S1P (10 μM) for 15, 30, 60, or 120 minutes.  Expression of the 
c-fos transcript was significantly increased by 15 minutes, maximal at 30 minutes, and 
returned to basal expression by 1 hour [Figure 2].  Expression of jun-B mRNA was also 
significantly increased at 15 minutes and maximal at 30 minutes, but remained elevated 
relative to baseline for up to 2 hours [Figure 3].  Expression of jun-B mRNA was 
stimulated in a dose-dependent fashion after incubating C6 cells for 30 minutes with S1P 
over a concentration range from 10 nM to 100 μM [Figure 4].   
Related lipids also induced c-fos expression.  Sphingosine (10 μM—183±20%), 
lysophosphatidic acid (LPA, 100 μM—188±41%), and sphingosylphosphorylcholine 
(SPC, 100 μM—420±44%) elicited significant rises in c-fos levels following 30 min of 
exposure. 
Subsequent experiments were conducted with S1P at 10 μM for 30 minutes.  
Inhibitors were added 30 minutes prior to agonist and were continued for the S1P 
incubation period. Co-incubation with the phospholipase C antagonist U73122 (10 μM) 
abolished c-fos expression stimulated by S1P [Figure 5].  Incubation with U73343 (10 
μM), the inactive analogue, had no inhibitory effect on S1P-stimulated c-fos mRNA 
levels.  Similar results were obtained with jun-B [Figure 6]. 
Pertussis toxin (100 ng/ml, 24 h) pre-exposure inhibited S1P-induced c-fos expression 
by 80% [Figure 7], and LPA-induced c-fos expression by 48% [Figure 8], whereas SPC-
induced c-fos expression was not significantly affected [Figure 9].   
RT-PCR analysis demonstrated that mRNAs for EDG receptors sensitive to LPA 







The current studies demonstrate that sphingosine-1-phosphate and the related lipids 
lysophosphatidic acid and sphingosylphosphorylcholine stimulate early response gene 
expression in C6 cells and that S1P induces c-fos expression occurs through a receptor-
dependent mechanism acting via Gi and phospholipase C. The data that support this 
conclusion are four-fold: 1) S1P stimulates time- and dose-dependent increases in c-fos 
and jun-B mRNA expression; 2) S1P effects on c-fos expression are suppressed by 
pertussis toxin, an inhibitor of Gi proteins; 3) S1P effects on c-fos expression are 
suppressed by U73122, an inhibitor of PLC; and 4) LPA receptors EDG-2 and EDG-4 are 
expressed in C6 cells. 
 While glial cells have traditionally been regarded as having passive, supportive 
functions in neural tissue, recent evidence suggests that these cells play an active role in 
information transfer within the brain, spinal cord, and at peripheral sites like the enteric 
nervous system (8, 9).  The finding that S1P is a potent agonist for immediate early gene 
expression signaling in C6 glioma cells, and that related lipids also have effects in these 
cells, implies that there may be multiple mechanisms for lipid signaling in glia.   
Sphingolipid metabolites such as S1P and its receptors have recently been shown to 
affect a wide variety of biological processes including cellular proliferation, migration 
and development, neurite retraction, and neuronal survival and differentiation (1-4, 10).  
S1P causes Ca2+ signaling in cultured CNS astrocytes and Ca2+ transients and shape 




induced early response gene expression in C6 cells.  The results presented here are 
congruent with previously described effects of S1P and related lipids upon Ca2+ signaling 
in glia. 
Goodemote et al. initially observed that S1P effects in Swiss 3T3 fibroblasts were 
pertussis toxin sensitive, suggesting this lipid possessed activity that resembled other 
agonists of G-protein-coupled receptors (GPCRs) (11).  The recent characterization of a 
family of GPCRs (EDG receptors) with affinity for S1P and related lipids has established 
a role for receptor-mediated lipid signaling events (10).  Previously an orphan receptor, 
EDG-1 was the first putative S1P receptor to be identified (12).  To date, seven additional 
EDG receptors have been identified that are differentially activated by S1P, SPC and 
LPA (5-7).   
The variety of sphingolipid signaling molecules that were demonstrated to induce c-
fos expression in C6 cells implies that multiple EDG receptors may be present in glia. 
EDG-1, EDG-3, EDG-5/H218/AGR16, EDG-6, and EDG-8 are responsive to S1P and, to 
a lesser degree, SPC, whereas EDG-2/Vzg-1, EDG-4, and EDG-7 appear to be selectively 
sensitive to LPA (5-7, 13).  Sato et al. have previously shown, by Northern blot analysis, 
that C6 glioma cells express mRNA for EDG-1 and EDG-5 (14).  The present study 
demonstrated that C6 cells also express mRNA for LPA receptors.  Using RT-PCR, 
EDG-2 and EDG-4 receptor mRNAs were demonstrated in cultured C6 cells.  The rat C6 
cell EDG-2 and EDG-4 receptors exhibited strong sequence homology with known 
mouse, rat and human EDG-2 and EDG 4 receptors, respectively.  The presence of a pair 
of LPA-activated EDG receptors is consistent with the production of Ca2+ responses in 




Hildebrandt (15) and  Tas and Koschel (16) and c-fos expression induction by LPA in C6 
cells as we present in this report.   The mRNA transcript for another LPA-specific 
receptor, EDG-7, was not detected in C6 cells.  
EDG-1, EDG-3, and EDG-5 have all been demonstrated to couple to Gi, but EDG-3 
and EDG-5 are also capable of interacting with Gq in transfected Sf9 and HEK293 cells 
(6).  If rat EDG-5 couples to Gq in C6 cells, S1P-induced c-fos expression may only be 
partially sensitive to PTX exposure.  In many cell types, Gq and Gi proteins link GPCRs 
with PLC.  The current studies convincingly demonstrate that S1P-induced c-fos 
expression is mediated by PLC as this action is antagonized by the PLC inhibitor 
U73122, but not by the inactive analog, U73343.  Other investigators have also reported 
that S1P signaling involves PLC (5).   
In support of a physiological source of S1P, recent studies indicate that upon 
activation with prothrombotic stimuli, platelets release amounts of S1P that increase 
serum levels to 500 nM, similar to concentrations used in these studies (4).  The 
recruitment and activation of platelets during an inflammatory response within nervous 
tisssue could produce local concentrations of S1P that would affect glia.   
In conclusion, C6 glioma cells exhibit receptor-mediated early response gene 
induction following treatment with sphingosine-1-phosphate.   The results suggest that 
C6 cells respond to bioactive lipids via a receptor-mediated mechanism that involves 
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Figure 4.1.  Northern blot analysis of dose-dependent expression of c-fos mRNA 
upon exposure to S1P.  C6 cells were treated with S1P over a concentration range of 
0.01 to 100 μM.  Blot is representative of data from four different experiments.  After 
hybridization, membranes were rehybridized using a GAPDH probe to control for 
variations in gel loading and transfer efficiency.  Data are compiled from an average of 







































Figure 4.2.  Time-dependent expression of c-fos mRNA.  C6 cells were treated with 
S1P (10 mM) for 15, 30, 60 and 120 min.  Significant increases in c-fos were noted by 15 













































Figure 4.3.  Northern blot analysis of dose-dependent expression of jun-B mRNA 
upon exposure to S1P.  C6 cells were treated with S1P over a concentration range of 
0.01 to 100 μM.  Data are compiled from an average of four separate experiments.  








































Figure 4.4.  Time-dependent expression of jun-B mRNA.  Significant increases in jun- 
B  were noted by 15 min.  C6 cells were treated with S1P (10 mM) for 15, 30, 60 and 120 






































Figure 4.5.  S1P effects upon c-fos involve phospholipase C activation.  C6 cells were 
exposed to S1P (10 μM) alone, or in addition to either U73122 (10 μM, a PLC 
antagonist) or U73343 (10 μM, an inactive PLC antagonist) for 30 min before c-fos 























































Figure 4.6.  S1P effects upon jun-B involve phospholipas C activation.  C6 cells were 
exposed to S1P (10 μM) alone, or in addition to either U73122 (10 μM, a PLC 
antagonist) or U73343 (10 μM, an inactive PLC antagonist) for 30 min before jun-B 
























































Figure 4.7.  S1P effects are PTX-sensitive.   Following incubation with pertussis toxin 





































































Figure 4.8.  LPA effects are PTX-sensitive.   Following incubation with pertussis toxin 





































































Figure 4.9.  SPC effects are PTX-insensitive.   Following incubation with pertussis 
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The work presented in this thesis was aimed at understanding the mechanisms of 
how signaling occurs in enteroglia.  This dissertation describes the effects of bioactive 
lipids on glial cells of the gastrointestinal tract, testing the overarching hypothesis that 
sphingosine-1-phosphate and related compounds affect signaling in these cells.  More 
specifically, these lipids are shown to activate calcium signaling in enteric glia, where 
numerous lipid-specific receptors are identified.  Efforts focus on elucidating the 
mechanisms of the signaling pathways involved.  Further, members of this diverse class 
of lipids are found to induce early response gene expression in C6 glioma cells, which are 
known to both respond to bioactive lipids with calcium signaling and express various 
receptors that transduce bioactive lipid effects.   
The bioactive lipids sphingosine-1-phosphate (S1P), lysophosphatidylcholine 
(LPA) and sphingosylphosphorylcholine (SPC) have been described in the scientific 
literature as unique signaling molecules in that they, while lipids, activate G protein-
coupled receptors (Endothelial Differentiation Gene receptors) on cell surfaces (1-11).  
Recently, lysophosphatidylcholine (LPC) has joined these ranks as it, too, has been found 
to serve as a ligand for yet another G protein-coupled receptor (which, incidentally, also 
share analogous activation by SPC) (11-13).  That such a diverse and rapidly expanding 
array of receptors may be selectively activated by these compounds emphasizes cells, 




notion that only peptides are responsible for transducing receptor-mediated responses.  
Even more intriguing is the consideration that at least two of these lipids (S1P and SPC) 
are believed to function through dual mechanisms:  extracellularly via their respective G 
protein-coupled receptors and intracellularly via one or more undefined receptors which 
appear to be analagous to the inositol trisphosphate receptor in that they lead to the 
mobilization of intracellular calcium stores (1-11).  Adding to the level of complexity, it 
has been shown that a variety of signaling molecules, including the LPA and S1P, 
stimulate intracellular S1P production (1-11).  In all, given the breadth of their effects 
upon cells from cytoprotection to proliferation (1-13), further uncovering the mechanisms 
for each of these lipids and determining their physiological, and potentially pathological, 
roles promises to continue to be an intriguing area of research.   
 It is an exciting time for glial biologists.  After decades of being overshadowed by 
neurons, it is clear that glia also serve critical roles in neural systems (14).  If, in spite of 
substantial progress, much work remains at the level of the central nervous system, then 
far greater effort is due in the enteric nervous system (ENS) where glia are still a great 
mystery.  Given the recent advances within the gastrointestinal tract to delineate the 
contribution of glia in health and disease, these once anonymous cells are now recognized 
as active elements in the gut (15-20).  The work presented here strongly supports a 
potential role for glia in information transfer within the walls of the bowel and beyond as 
we demonstrate the increasing diversity of signaling events displayed by these cells.   
Chapter 1 of this thesis lays the foundation of this investigation by demonstrating 
that enteric glia display similarities to glia of the central nervous system both structurally 




one readily appreciates the potential for glial involvement in active signaling within the 
gut (15-24).  Data are provided depicting responsiveness to the neuroligands ATP and 
endothelin with calcium signaling and these mechanisms are dissected.  Calcium 
signaling is a foundational element of intra- and intercellular communication.  This is 
seen in the central nervous system where glial cells are known to propagate signals 
among themselves and also felt to have the potential to modulate neuronal activity and 
synaptic transmission (14).    
Although somewhat teliologic in argument, these results beg the question, "Why 
would cells  be equipped to signal in this analogous manner if not involved in the 
essential transfer of information in the gastrointestinal tract?"  The sentinel observation of 
enteroglial agonist-induced calcium by earlier studies in our laboratory raised the 
possibility that these cells serve as messengers under physiologic circumstances.  Others 
have similarly proposed that plasticity is found within the ENS and that neurons and glia 
alike play a prominent role in this microenvironment through propagation of signals, 
cytoskeletal changes and neurotransmission (17). 
Further, on the pathophysiologic front, by identifying molecules involved in 
inflammation or disease states which in turn induce glial signals, a potential link between 
the two is established.  While definitive data linking the two are not made by this body of 
work, the postulate that enteric glia and inflammation and disease within the GI tract are 
associated represents a natural extension of this research.  The observation by Bush, et al. 
that the ablation of enteroglial cells in transgenic mice leads to fatal fulminant jejuno-
ileitis serves as further evidence that these cells may have an immunomodulatory role in 




in Hirschsprung's disease, a congenital condition wherein the enteric nervous system fails 
to development normally.  Aberrant endothelin signaling is a major culprit for this 
gastrointestinal defect remedied only by surgery in young infants, once again hinting at 
an association between enteric glia and its neuroligands (of note, enteric neurons are 
unresponsive to endothelin) (25-39).  Chapter 1 serves as the introduction to this thesis by 
substantiating that enteric glia have unique signaling characteristics, without which 
enteric neurons, the gastrointestinal tract, and the organism as a whole would be 
incapable of survival. 
In Chapter 2, a study of the actions of a novel lipid compound in the ENS is 
revealed.  This series of investigations was conducted with again the long-term goal of 
understanding neurotransmission within the gut.  Enteric glia, rather than enteric neurons, 
are found to selectively respond to a bioactive lipids.  The sphingomyelin metabolite 
sphingosine-1-phosphate (S1P) causes dose-dependent, pertussis toxin-insensitive 
calcium (Ca2+) signaling utilizing extracellular and intracellular Ca2+ in a manner which 
appears to be receptor-mediated.  Several S1P-coupled endothelial differentiation gene 
(EDG) receptor mRNAs (EDG-1, EDG-3, and EDG-5) are found within the ENS with 
enteric glial cells demonstrating strong expression of both EDG-1 and EDG-3 and weak 
expression of EDG-5.  Further, other sphingomyelin cycle components (sphingomyelin, 
sphingomyelinase, and sphingosine) also activate Ca2+ signaling in enteric glia, leading to 
the postulate that these cells are capable of processing sphingolipids to elicit intracellular 
S1P responses.  The  related lipids lysophosphatidic acid (LPA) and 
sphingosylphosphorylcholine (SPC)—agonists of differing EDG receptors—are also 




multiple lipid-activated signaling mechanisms exist in these cells, leading to the 
hypothesis that S1P and other bioactive lipids function as novel signaling molecules 
within the ENS to facilitate information transfer. 
   The natural extension of the studies in Chapter 2, a more detailed investigation 
into the role of LPA in enteric glia, is the substance of Chapter 3.  Again, enteroglia are 
found to selectively respond to this product of phosphatidylcholine metabolism while 
enteric neurons fail to generate calcium signals in response to this lipid.  LPA causes 
dose-dependent calcium (Ca2+) signaling in these cells at what are believed to be 
physiologic levels.  Its acts through what appears to be an extracellular receptor, at least 
partially involving a G protein of the Gi subtype.  RT-PCR analysis demonstrated the 
presence of two LPA-coupled EDG receptor mRNAs (EDG-2 and EDG-7) in myenteric 
plexus primary cultures and EDG-2 expression in glial cells of the ENS was confirmed 
immunocytochemically.  Taken together with our previous data on S1P signaling in 
enteric glia, the conclusion was drawn from this body of evidence uncovering the role of 
LPA that multiple lipid-activated signaling mechanisms exist in these cells.   
Although these data supported a role for S1P functioning via an extracellular 
receptor in glia, the intracellular signaling pathways subsequently activated remained 
incompletely defined.  The studies in Chapter 4 were designed to disclose whether S1P 
and related lipids would induce expression of the immediate early response genes c-fos 
and jun-B in a model glial cell line: C6 glioma cells.  These proto-oncogenes, members 
of a well-characterized family of immediate early response genes, were chosen with the 
hope of further characterizing lipid-mediated intracellular signaling events at the 




dependent expression of c-fos and jun-B expression; 2) c-fos expression was blocked by 
pertussis toxin (PTX), a Gi antagonist, and by U73122, an inhibitor of phospholipase C; 
3) the related sphingolipids sphingosylphosphorylcholine and LPA also stimulated c-fos 
expression and displayed differential sensitivity to PTX; and 4) EDG-2 and EDG-4 




A conclusion of this thesis would be remiss without at least a brief discussion of 
ideas for future efforts.  They likely include the identification and further characterization 
of other bioactive lipids affecting glial signaling (see following section for preliminary 
data on the related lipids sphingosylphosphorylcholine and lysophosphatidylcholine) and 
a deeper look into the biological effects of bioactive lipid treatment in the ENS.  For 
example, results from our lab and others suggests that these lipid molecules may induce 
cytoskeletal changes and gene expression in glial cells, including those of the ENS.  The 
evolution of this and other projects that both grew and will grow out of the initial 
observation one evening a few years ago that S1P strongly activates calcium signaling in 
enteroglia shall prove fascinating.  Creativity and persistence will be essential to 
overcome limitations of the current model, including the possible generation of a reliable 
enteric glial cell line or the ability to otherwise produce large qualities of purified primary 
cell populations.  Decoding the signals of glia as they actively participate in information 
transfer in the gastrointestinal tract will continue to generate excitement and attract more 




timely movement as a developing scientist and clinician.  In the ensuing paragraphs, 
some exciting preliminary data will be shared as an adjunct to data born by this thesis 
followed by a summary diagram depicting the data discussed in this final chapter [Figure 
5.7]. 
 
A Role for Sphingosylphosphorylcholine (SPC) and Lysophosphatidylcholine (LPC) 
in the Enteric Nervous System. 
Abstract 
 
 Bioactive lipids consist of a growing family of molecules with the ability to 
transduce a variety of cellular responses in numerous cell models. 
Sphingosylphosphorylcholine (SPC) and lysophosphatidylcholine (LPC) are bioactive 
lipids that have been studied for years yet have only recently been shown to activate 
receptor-mediated pathways.  In this section, the effects of SPC and LPC upon calcium 
signaling in glial cells of the enteric nervous system (ENS) are revealed.  In short, SPC 
and LPC both cause robust calcium signaling in enteric glia.  These responses appear to 
be receptor mediated as they rapidly desensitize with repetitive exposure.  Further these 
two compounds have differential sensitivity to pertussis toxin (PTX):  SPC responses are 
attenuated with PTX pretreatment (and, thus, are likely Gi coupled) whereas LPC 
responses are not.  SPC and LPC represent two additional means by which enteric glia 







As has been discussed in this thesis, our understanding of the role of glia in the 
gastrointestinal tract is evolving at a rapid pace.  The evidence for these previously 
enigmatic cells to serve in an active fashion, like their counterparts in the central nervous 
system is overwhelming.  That they possess the ability to undergo calcium signaling in 
response to a diverse array of compounds suggests they may be active participants in 
information transfer in the neural circuit found within the wall of the bowel.  Other 
studies suggest that they may be clinically relevant as potential culprits in inflammatory 
bowel disease and Hirschsprung's disease.   
Sphingosylphosphorylcholine (SPC) is a bioactive lipid that participates in a 
number of biological processes by serving as a signaling molecule (2, 3, 6, 10- 13).  As 
discussed in previous chapters, early reports found that SPC shared activation of select 
Endothelial Differentiation Gene receptors with sphingosine-1-phosphate.  The first G 
protein-coupled receptor found to be specific for SPC was OGR1 (40).  Due to 
similarities found with Platelet Activating Factor (PAF) receptor, it was postulated that a 
subfamily of receptors existed for lysolipids possessing the phosphorylcholine moiety 
(12).  Lysophoshatidylcholine (LPC) is such a naturally occurring compound that has 
been described to participate in a variety of cellular effects including inflammation and 
atherosclerosis (11).  Indeed, LPC was recently identified as the ligand for the 
immunoregulatory receptor G2A (41, 42).  Further, emphasizing the ability of the related 
compounds to function similarly, both SPC and LPC were subsequently discovered to 





Sphingosylphosphorylcholine (SPC) and Lysophosphatidylcholine (LPC) Cause Ca2+ 
Signaling in Enteric Glia.   
 
Previously, to determine whether cultured guinea pig enteric glial cells were 
responsive to bioactive lipids, mixed primary cultures of myenteric plexus were exposed 
to an array of related lipid compounds.  Those studies revealed that only enteric glia 
selectively underwent Ca2+ signaling in response to a variety of, but not all, lipids 
including sphingosine-1-phosphate (S1P), LPA (1μM) and SPC (1μM).  Interestingly, 
enteric neurons did not display Ca2+ signaling following treatment with S1P, LPA, SPC, 
or any other lipids evualated.  Similarly for these studies, no neurons responded to LPC. 
Perfusion of glial cells with SPC (10 μM) and LPC (10 μM) (doses utilized 
routinely in the literature) for 120s caused strong Ca2+ mobilization in (100%, Δ [Ca2+]i = 
313±27 nM, n=112) and (100%, Δ [Ca2+]i =408±35 nM, n=109) of glial cells, 






SPC- and LPC-mediated Ca2+ Signaling Desensitizes with Repetitive Exposure.   
 
Repetitive exposure to either SPC or LPC produced progressive decrements in 
calcium transients generated in enteric glia [Figures 5.3 and 5.4].  For SPC, an 
approximately 76% decrease in peak [Ca2+]i responses was observed between the first 
and second exposures, and another decrement of 14% between the second and third 
exposures.  100% of cells responded initially to SPC and 35% completely desensitized 
(n=107).  For LPC, an approximately 48% decrease in Δ [Ca2+]i responses was observed 
between the first and second exposures, and another decrement of 34% between the 
second and third exposures.  100% of cells responded to LPC and 13% completely 
desensitized (n=98).  To demonstrate that the effect was not due to depletion of 
intracellular Ca2+ stores, cells were subsequently perfused with ATP (100 μM) at the end 
of each experiment and typical  increments in [Ca2+]i were achieved.  Desensitization is 
typical of receptor-mediated events. 
 
SPC and LPC Responses are Differentially Sensitive to Pertussis Toxin (PTX).   
 
To investigate the involvement of a PTX-sensitive G protein, enteric glia were 
preincubated with PTX at 100 ng/ml for 24 h, a concentration and preincubation time 
found to be effective in earlier studies.  The Δ [Ca2+]i generated by SPC in all glia pre-
exposed to PTX was 62+34 nM (n=97), relative to the peak [Ca2+]i evoked in control glia 
of 243+29 nM (n=131).  An averaged tracing from an individual run (n=36) is included 




groups:  41% vs. 100% for PTX-treated and non PTX-treated cells, respectively.  The Δ 
[Ca2+]i generated by LPC in glia pre-exposed to PTX was 481+37 nM (n=116), relative to 
the Δ [Ca2+]i evoked in control glia of 409+28 nM (n=140).  An averaged tracing from an 
individual run (n=56) is included [Figure 5.6].  The percentage of cells responding to 
LPC was identical in the two groups:  100% and 100% for PTX-treated and non PTX-
treated cells, respectively.   
 
Discussion 
SPC and LPC represent two additional lysolipids in the complex and developing 
picture of bioactive lipid signaling in enteric glia.  This report addresses in brief fashion 
their effects in these cells and presents evidence which supports a role for receptor-
mediated SPC and LPC calcium signaling.  In enteric glia, SPC and LPC cause robust 
calcium signaling which is rapidly desensitized and differentially sensitive to pertuss-
toxin pre-treatment. 
That SPC and LPC have diverse biological effects has been known for quite some 
time.  However, the finding that they activate cell surface receptors has added to the 
intrigue of these compounds.  They join a list of growing bioactive lipids which retain the 
ability to function through G protein-coupled receptors.  This dissertation has already 
characterized the effects of S1P and LPA in enteric glia and, to this end, the discovery of 
SPC and LPC actions now raise the level of diversity exhibited by these cells.  
This section serves as an abbreviated account of SPC and LPC functioning via 




the receptors discussed herein.  However, while it is not shown that glial cells of the 
gastrointestinal tract express GPR4, G2A, or OGR1, the responsiveness of these cells is 
consistent with receptor-mediated events.  In fact, data have already been presented to 
show that two SPC-activated Endothelial Differentiation Gene receptors (EDG-1 and 
EDG-3) are present in enteric glia (see Chapter 2).  Rapid desensitization is typical of 
receptor-mediated events, as was observed following SPC and LPC treatment.  While 
SPC-generated calcium signals were PTX-sensitive, those generated by LPC were not, 
showing divergence of signaling pathways.  This finding was a bit surprising since the 
receptors identified to date for either SPC or LPC are all at least partially coupled to the 
protein Gi following receptor activation.  Accordingly, it remains possible that LPC is 
coupled to an as of yet unidentified receptor in enteric glia.  Future work will need to be 
directed towards both further characterizing the receptor-mediated signaling events in 
















Figure 5.1.  Sphingosylphosphorylcholine (SPC) causes Ca2+ signaling in enteric 
glia.  Cultured enteric glial cells exposed to 10 μM SPC.  Tracing is a representative 





















































Figure 5.2.  Lysophosphatidylcholine (LPC) causes Ca2+ signaling in enteric glia.  
Cultured enteric glial cells exposed to 10 μM LPC.  Tracing is a representative sample of 
























































Figure 5.3.  SPC-mediated Ca2+ signaling desensitizes with repetitive exposure.  
Cultured enteric glial cells exposed to 10 μM SPC sequentially after periods of agonist 
washout and recovery followed by stimulation by ATP (100 μM) to demonstrate 
intracellular calcium stores are not depleted.  Tracing is a representative sample of over 
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Figure 5.4.  LPC-mediated Ca2+ signaling desensitizes with repetitive exposure.    
Cultured enteric glial cells exposed to 10 μM LPC sequentially after periods of agonist 
washout and recovery followed by stimulation by ATP (100 μM) to demonstrate 
intracellular calcium stores are not depleted.  Tracing is a representative sample of over 























































Figure 5.5.  SPC responses are sensitive to pertussis toxin (PTX).  Cultured enteric 
glial cells were incubated with 100 ng/ml PTX for 24 h and then exposed to 10 μM SPC. 
Following pretreatment, cells display diminished responsiveness to SPC as shown.  

























































Figure 5.6.  LPC responses are not sensitive to pertussis toxin (PTX).  Cultured 
enteric glial cells were incubated with 100 ng/ml PTX for 24 h and then exposed to 10 
μM LPC. Following pretreatment, cells remain responsive to LPC as shown.  Tracing 
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